Document:

EX-10.17

 Exhibit 10.17 
 LOAN AGREEMENT 
 THIS LOAN AGREEMENT (this
“Agreement”), dated as of October 2, 2012, is made by and among Marrone Bio Innovations, Inc., a Delaware corporation (the “Company”), each of the Lenders named on the signature pages of this Agreement (each a
“Lender” and, collectively, the “Lenders”), and Gordon Snyder, an individual (“Snyder”), as administrative agent and collateral agent for the Lenders (in such capacity, the
“Agent”). 
 The Company has requested that the Lenders make term loans to the Company in an aggregate
principal amount of up to $7,500,000 and that the Agent agree to act as administrative agent and collateral agent for the benefit of the Lenders with respect thereto. 
 The Company, the Agent, and the Lenders desire to enter into this Agreement to evidence the willingness of the Lenders to provide the term loan facility and of the Agent to act on behalf of the Lenders
and to set forth the rights and obligations of the parties with respect to such credit facility. 
 Accordingly, the parties
hereto agree as follows: 
 ARTICLE I 
 DEFINITIONS 
 SECTION 1.01 Certain Defined Terms. As used in this
Agreement (including in the recitals hereof), the following terms shall have the following meanings: 
 “Acquired
Indebtedness” means Indebtedness of a Person whose assets or stock is acquired by the Company in a Permitted Acquisition; provided, however, that such Indebtedness (i) was in existence prior to the date of such Permitted
Acquisition, and (ii) was not incurred in connection with, or in contemplation of, such Permitted Acquisition. 

“Administrative Agency Fee” has the meaning set forth in Section 2.05. 

“Affiliate” means any Person which, directly or indirectly, controls, is controlled by or is under common control with
another Person. For purposes of the foregoing, “control,” “controlled by” and “under common control with” with respect to any Person shall mean the possession, directly or indirectly, of the power (i) to vote 10%
or more of the securities having ordinary voting power of the election of directors of such Person, or (ii) to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities or by
contract or otherwise. 
 “Agent” has the meaning set forth in the recital of parties to this Agreement.

 “Applicable Maturity Date” means, with respect to each Loan, the date when such Loan is paid in full or
otherwise no longer outstanding. 
 “Assignment and Assumption” has the meaning set forth in
Section 9.07(b)(ii). 
 “Bankruptcy Code” means Title 11 of the United States Code entitled
“Bankruptcy.” 
 “Business Day” means a day other than a Saturday or a Sunday on which banks are open
for business in California. 

  
 1 

 “Closing Date” has the meaning set forth in Section 3.01.

 “Code” means the California Uniform Commercial Code, as in effect from time to time. 

“Collateral” means the property described in the Collateral Documents, and all other property now existing or hereafter
acquired which may at any time be or become subject to a Lien in favor of the Agent for the benefit of the Lenders pursuant to the Collateral Documents or otherwise, securing the payment and performance of the Obligations. 

“Collateral Documents” means any Security Agreement, any pledge agreement or any other agreement pursuant to which the
Company or any other Person provides a Lien on its assets in favor of the Agent for the benefit of the Lenders, and all filings, documents and agreements made or delivered pursuant thereto. 

“Commitment” means, as to any Lender, the amount set forth opposite its name on Schedule 1, or, where the context
so requires, the obligation of such Lender to make its Loan up to such amount on the terms and conditions set forth in this Agreement. 
 “Company” has the meaning set forth in the recital of parties to this Agreement. 
 “Company IPO” means the Company’s initial public offering of common stock. 
 “Convertible Note Financing October 2012” means the financing pursuant to that certain Loan Agreement, dated as of October 16, 2012, by and among the lenders from time to time party
thereto, Snyder, as administrative agent and collateral agent for such lenders, and the Company relating to the term loans in an aggregate amount of up to $2,500,000, as such agreement is amended, restated, supplemented or otherwise modified from
time to time. 
 “Default” means an Event of Default or an event or condition which with notice or lapse of
time or both would constitute an Event of Default. 
 “Dollars” and the sign “$” each means
lawful money of the United States. 
 “Environmental Laws” means all federal, state or local laws, statutes,
common law duties, rules, regulations, ordinances and codes, together with all administrative orders, directives, requests, licenses, authorizations and permits of, and agreements with (including consent decrees), any governmental agencies or
authorities, in each case relating to or imposing liability or standards of conduct concerning public health, safety and environmental protection matters. 
 “ERISA” means the Employee Retirement Income Security Act of 1974, including (unless the context otherwise requires) any rules or regulations promulgated thereunder. 

“Event of Default” has the meaning set forth in Section 6.01. 

“First Extended Term” means the period of time commencing from and after (but not including) the Initial Maturity Date
until October __, 2016. 
 “GAAP” means generally accepted principles of good accounting practice in the United
States, consistently applied. 
 “Highest Lawful Rate” has the meaning set forth in Section 2.07.

  
 2 

 “Indebtedness” any indebtedness or obligation for borrowed money, the
deferred purchase price of property or leases which would be capitalized in accordance with GAAP, any reimbursement and other obligations in respect of letters of credit and surety or performance bonds, and all net obligations in respect of
derivative products; and any liability as a surety, guarantor, accommodation party or otherwise for or upon the indebtedness or obligation of any other Person of the nature described above. 

“Initial Maturity Date” means October __, 2015. 

“Insolvency Proceeding” means (i) any case, action or proceeding before any court or other governmental agency or
authority relating to bankruptcy, reorganization, insolvency, liquidation, receivership, dissolution, winding-up or relief of debtors, or (ii) any general assignment for the benefit of creditors, composition, marshalling of assets for
creditors, or other, similar arrangement in respect of any Person’s creditors generally or any substantial portion of such Person’s creditors, in each case undertaken under U.S. Federal, state or foreign law, including the Bankruptcy Code.

 “Intercreditor Agreement” means an intercreditor agreement or agreement among lenders or similar agreement
between Snyder, as agent for the Lenders party hereto and the lenders party to the Loan Agreement with respect to the Convertible Note Financing October 2012, and Point setting forth the rights and obligations of such Persons with respect to the
security interests granted to such Persons in and to the property of the Company. 
 “Internal Revenue Code”
means the Internal Revenue Code of 1986, including (unless the context otherwise requires) any rules or regulations promulgated thereunder. 
 “IRS” means the Internal Revenue Service or any successor thereto. 
 “Lender” and “Lenders” have the respective meanings set forth in the recital of parties to this Agreement. 

“Lien” means any mortgage, deed of trust, pledge, security interest, assignment, deposit arrangement in the nature of a
security interest, charge or encumbrance, lien or other type of preferential arrangement (other than a financing statement filed by a lessor in respect of an operating lease not intended as security). 

“Loan” and “Loans” have the respective meanings set forth in Section 2.01. 

“Loan Documents” means this Agreement, the Notes, the Collateral Documents, any Subordination Agreement, and all other
certificates, documents, agreements and instruments required to be delivered to the Agent or the Lenders under or in connection with this Agreement. 
 “Majority Lenders” has the meaning set forth in Section 7.03. 
 “Material Adverse Effect” means any change, occurrence, event, circumstance or development that has had or could reasonably be expected to have a material adverse effect on (i) the
business, properties, assets, liabilities, financial condition, operation or performance of the Company; or (ii) the validity or enforceability of any of the Loan Documents or the rights and remedies of the Agent or the Lenders hereunder.

 “Michigan Facility” means the plant facility located in Bangor, Michigan. 

  
 3 

 “MMM” means Marrone Michigan Manufacturing, LLC, a Delaware limited
liability subsidiary. 
 “Note” has the meaning set forth in Section 2.03. 

“Obligations” means the indebtedness, liabilities and other obligations of the Company to the Agent and the Lenders
under or in connection with the Loan Documents, including the Loans, all interest accrued thereon, all fees due under this Agreement and all other amounts payable by the Company to the Agent or any Lender thereunder or in connection therewith,
whether now or hereafter existing or arising, and whether due or to become due, absolute or contingent, liquidated or unliquidated, determined or undetermined. 
 “Organic Documents” means, relative to any Person, its articles or certificate of incorporation, or certificate of limited partnership or formation, and its bylaws, partnership or
operating agreement or other organizational documents. 
 “Permitted Acquisition” means any acquisition so long
as: 
 (i) no Event of Default shall have occurred and be continuing or would result from the consummation of
the proposed acquisition and the proposed acquisition is consensual; 
 (ii) no Indebtedness will be incurred,
assumed, or would exist with respect to the Company as a result of such acquisition, other than Indebtedness permitted under Section 5.03(a)(xi) and (xii) and no Liens will be incurred, assumed, or would exist with respect to the
assets of the Company as a result of such acquisition other than Permitted Liens; 
 (iii) the Company has
provided the Agent with written notice of the proposed acquisition at least five (5) days prior to the anticipated closing date of the proposed acquisition and, not later than two (2) days prior to the anticipated closing date of the
proposed acquisition, copies of the acquisition agreement and other material documents relative to the proposed acquisition; 
 (iv) the assets being acquired (other than a de minimis amount of assets in relation to the Company’s total assets), or the Person whose stock is being acquired, are useful in or engaged in,
as applicable, the business of the Company or a business reasonably related thereto; and 
 (v) prior to the
closing of the Company IPO, the purchase consideration payable in respect of all Permitted Acquisitions (including the proposed acquisition and including deferred payment obligations) shall not exceed $30,000,000 in the aggregate (it being agreed
and acknowledged by the Agent, the Lenders, and the Company that on, in connection with, or after the closing of the Company IPO, there shall not be a limit as to the purchase consideration payable in respect of Permitted Acquisitions). 

“Permitted Liens” has the meaning set forth in Section 5.03(b). 

“Person” means an individual, corporation, partnership, limited liability company, joint venture, trust, unincorporated
organization or any other entity of whatever nature or any governmental agency or authority. 
 “Point” means
Point Financial, Inc. 

  
 4 

 “Point Security Agreement” means that certain Security Agreement, dated
April 13, 2012, by and between the Company and Point, as such agreement is amended, restated, supplemented or otherwise modified from time to time; provided, however, that the principal amount of the indebtedness evidenced or secured by
the Point Security Agreement is not increased except by an amount equal to a reasonable premium or other reasonable amount paid, and fees and expenses reasonably incurred, in connection with such amendment, restatement, supplement or other
modification. 
 “Prepayment Notice” has the meaning set forth in Section 2.09(a). 

“Pro Rata Share” means, as to any Lender at any time, the percentage equivalent (expressed as a decimal) at such time of
such Lender’s Commitment divided by the combined Commitments of all Lenders (or, if all Commitments have been terminated, the aggregate principal amount of such Lender’s Loans divided by the aggregate principal amount of the Loans then
held by all Lenders). The initial Pro Rata Share of each Lender is set forth opposite such Lender’s name in Schedule 1 under the heading “Pro Rata Share.” 

“Purchase Money Indebtedness” means Indebtedness incurred to finance the acquisition of fixed assets, capital assets
(whether pursuant to a loan, a capitalized lease or otherwise) or other assets (including manufacturing plants), including the development, furnishing and operation hereof. 
 “Responsible Officer” means, with respect to any Person, the chief executive officer, the president, the chief financial officer or the treasurer of such Person, or any other senior
officer of such Person having substantially the same authority and responsibility. 
 “Sale of the Company”
means (a) a sale or transfer of all or substantially all of the Company’s assets, or (b) the acquisition of the Company by means of any transaction or series of related transactions (including, without limitation, any reorganization,
merger or consolidation) that results in the transfer of more than 50% of the outstanding voting power of the Company; provided that a transaction shall not constitute a Sale of the Company if its sole purpose is to change the state of the
Company’s incorporation or to create a holding company that will be owned in substantially the same proportions by the Persons who held the Company’s securities immediately before such transaction. 

“SEC” means the Securities and Exchange Commission, or any successor thereto. 

“Securities Act” has the meaning set forth in Section 8.01(c). 

“Second Extended Term” means the period of time commencing from and after (but not including) the First Extended Term
until October __, 2017. 
 “Security Agreements” means (a) a Security Agreement between the Company and
the Agent, and (b) a Security Agreement between MMM and the Agent, in each case, in form and substance reasonably satisfactory to the Agent. 
 “Snyder” has the meaning set forth in the recital of parties to this Agreement. 
 “Subordinated Debt” means any Indebtedness of the Company subordinated to the Obligations, incurred or outstanding in accordance with Section 5.03(a)(xv) and subject to a
Subordination Agreement. 

  
 5 

 “Subordination Agreement” means any subordination agreement with respect to
Subordinated Debt among the Company, the applicable creditor(s) and the Agent, in form and substance reasonably satisfactory to the Agent. 
 “Subsidiary” means any corporation, association, partnership, limited liability company, joint venture or other business entity of which more than 50% of the voting stock or other equity
interest is owned directly or indirectly by any Person or one or more of the other Subsidiaries of such Person or a combination thereof. 
 “United States” and “U.S.” each means the United States of America. 
 SECTION 1.02 Accounting Terms. Unless otherwise defined or the context otherwise requires, all accounting terms not expressly defined herein shall be construed, and all accounting determinations
and computations required under this Agreement or any other Loan Document shall be made, in accordance with GAAP. 
 SECTION
1.03 Interpretation. In the Loan Documents, except to the extent the context otherwise requires: (i) any reference to an Article, a Section, a Schedule or an Exhibit is a reference to an article or Section thereof, or a schedule or an
exhibit thereto, respectively, and to a subsection or a clause is, unless otherwise stated, a reference to a subsection or a clause of the Section or subsection in which the reference appears; (ii) the words “hereof,”
“herein,” “hereto,” “hereunder” and the like mean and refer to this Agreement or any other Loan Document as a whole and not merely to the specific Article, Section, subsection, paragraph or clause in which the
respective word appears; (iii) the meaning of defined terms shall be equally applicable to both the singular and plural forms of the terms defined; (iv) the words “including,” “includes” and “include” shall be
deemed to be followed by the words “without limitation;” (v) references to agreements and other contractual instruments shall be deemed to include all subsequent amendments and other modifications thereto, but only to the extent such
amendments and other modifications are not prohibited by the terms of the Loan Documents; (vi) references to statutes or regulations are to be construed as including all statutory and regulatory provisions consolidating, amending,
supplementing, interpreting or replacing the statute or regulation referred to; (vii) any table of contents, captions and headings are for convenience of reference only and shall not affect the construction of this Agreement or any other Loan
Document; and (viii) in the computation of periods of time from a specified date to a later specified date, the word “from” means “from and including”; the words “to” and “until” each mean “to but
excluding”; and the word “through” means “to and including.” 
 ARTICLE II 

THE LOAN 

SECTION 2.01 The Loans. Each Lender severally agrees, on the terms and conditions hereinafter set forth, to make a term loan
(each, a “Loan” and collectively, the “Loans”) to the Company on or after the Closing Date, in a principal amount up to but not exceeding its Commitment. The Loans advanced to the Company hereunder shall equal an
aggregate principal amount of up to $7,500,000. 

  
 6 

 SECTION 2.02 Maturity. The principal amount of the Loans shall be due and payable on
the Initial Maturity Date, subject to (a) an extension until the last day of the First Extended Term at the option of the Company by providing written notice to the Agent of such extension prior to the Initial Maturity Date, and (b) an
additional extension until the last day of the Second Extended Term at the option of the Company by providing written notice to the Agent of such extension prior to the last day of the First Extended Term; provided that, in the case of
each of (a) and (b), no Event of Default shall have occurred and be continuing on the date the Company provides such written notice. 
 SECTION 2.03 Evidence of Indebtedness. As additional evidence of the Indebtedness of the Company to each Lender resulting from the Loan made by such Lender, upon such Lender’s written request
(which request shall be communicated in writing by the Agent to the Company), the Company shall execute and deliver to each Lender a promissory note, in the principal amount of the Loan made by such Lender (a “Note”). 

SECTION 2.04 Interest. The Company shall pay to each Lender interest on the unpaid principal amount of the Loan made by such
Lender (in each of the following cases, with such interest to be paid monthly in arrears on the last Business Day in each month), (a) from the date of such Loan until and including the Initial Maturity Date, at a rate per annum equal to 12%,
(b) from and after Initial Maturity Date until and including the last day of the First Extended Term (if applicable), at a rate per annum equal to 13%, (c) from and after the first day of the First Extended Term until and including the
last day of the Second Extended Term (if applicable), at a rate per annum equal to 14%. After the occurrence and during the continuance of an Event of Default pursuant to Section 6.01(a), interest on the unpaid principal balance of the
Loan shall accrue until all obligations of the Company to each Lender have been paid in full, at a rate per annum equal to 18%. 
 SECTION 2.05 Fees. The Company agrees to pay to the Agent a fee (the “Administrative Agency Fee”) equal to (a) if the Applicable Maturity Date is on or before the Initial
Maturity Date, 5% of the principal amount of the Loans funded hereunder, (b) if the Applicable Maturity Date is after the Initial Maturity Date but on or before the last day of the First Extended Term, 6% of the principal amount of the Loans
funded hereunder, and (c) if the Applicable Maturity Date is after the First Extended Term but on or before the last day of the Second Extended Term, 7% of the principal amount of the Loans funded hereunder, which fee shall be payable within
thirty days following repayment in full of the Loans pursuant to Section 2.08. All fees payable under this Section 2.05 shall be nonrefundable. 
 SECTION 2.06 Computations. All computations of fees and interest hereunder shall be made on the basis of a year of 360 days for the actual number of days occurring in the period for which any such
interest or fee is payable. 
 SECTION 2.07 Highest Lawful Rate. In no event shall the Company be obligated to pay the
Lenders interest, charges or fees at a rate in excess of the highest rate permitted by applicable law (the “Highest Lawful Rate”); provided, however, that notwithstanding the foregoing, the Company shall pay the
Lenders such interest, charges, and fees not in excess of the Highest Lawful Rate as required by the terms of this Agreement. 

  
 7 

 SECTION 2.08 Repayment of the Loans. The Company shall repay to each Lender the
principal amount of the Loan made by such Lender in full plus all accrued but unpaid interest on the Applicable Maturity Date pursuant to Section 2.02. 
 SECTION 2.09 Prepayments of the Loans. 
 (a) Optional
Prepayments. Upon the earliest of (i) the date that is six months after the Closing Date, (ii) the closing of the Company IPO, and (iii) the date on which a Sale of the Company is consummated, the Company may, upon 30 days’
prior written notice to the Agent, prepay the outstanding amount of the Loans in whole or in part, without premium or penalty; provided that if the Company provides written notice to the Agent pursuant to this Section 2.09(a) (any
such notice, a “Prepayment Notice”) buts fails to prepay the amount of the Loans to be prepaid as set forth in such Prepayment Notice on the prepayment date as set forth in such Prepayment Notice, then the Agent shall have the right
to declare an Event of Default by providing the Company with two (2) Business Days’ prior written notice thereof; provided, further, that the first proviso of this Section 2.09(a) shall not apply (and for the
avoidance of doubt, the Agent shall not have any right to declare any Event of Default) in the event of any Prepayment Notice provided to the Agent in connection with, or in contemplation of, (x) the closing of the Company IPO, (y) any
Sale of the Company, or (z) any equity financing of the Company. 
 (b) Notice; Application. The notice given of any
prepayment shall specify the date and amount of the prepayment. If the notice of prepayment is given, the Company shall make such prepayment and the prepayment amount specified in such notice shall be due and payable on the date specified therein,
with accrued interest to such date on the amount prepaid. Partial prepayments of the Loans shall be applied to the installments of principal thereof as determined by the Company in its sole discretion.  

SECTION 2.10 Payments. 
 (a) Payments. Each payment made by the Company shall be made to the Agent not later than 5:00 p.m. (California time) on the day when due in Dollars and in same day funds, or such other funds as
shall be separately agreed upon by the Company and the Agent, in accordance with the Agent’s wire instructions or other instructions provided in writing to the Company. 
 (b) Extension. Whenever any payment hereunder shall be stated to be due, or whenever any interest payment date or any other date specified hereunder would otherwise occur, on a day other than a
Business Day, then, except as otherwise provided herein, such payment shall be made, and such interest payment date or other date shall occur, on the next succeeding Business Day, and such extension of time shall in such case be included in the
computation of payment of interest or per annum fee hereunder. 

  
 8 

 (c) Application. After the exercise of remedies provided for in
Section 6.02 (or after the Loans have automatically become immediately due and payable as set forth in Section 6.02) each payment by or on behalf of the Company hereunder shall be applied (i) first, to any fees, costs,
expenses and other amounts (other than principal and interest) due the Lenders; (ii) second, to accrued and unpaid interest due the Lenders; (iii) third, to principal due the Lenders, (iv) fourth, to the payment of fees due to the
Agent pursuant to Section 2.05, and (v) fifth, the balance, if any, after all Obligations have been indefeasibly paid in full, to the Company or as otherwise required by applicable law. 

(d) Subordination of Indebtedness Under the Convertible Note Financing October 2012. As set forth in the Loan Agreement with
respect to the Convertible Note Financing October 2012, the lenders party thereto and Snyder, as administrative agent and collateral agent for such lenders, have agreed to subordinate all of the Company’s Indebtedness and other obligations to
such lenders and Snyder in connection with the Convertible Note Financing October 2012 to all of the Company’s Indebtedness and other obligations to the Agent and the Lenders party to this Agreement. 

(e) Pro Rata Treatment. 
 (f) Except as otherwise provided in this Agreement, each borrowing hereunder and each payment (including each prepayment) by the Company on account of the principal of and interest on the Loans and on
account of any fees shall be made ratably in accordance with the respective Pro Rata Shares of the Lenders. 
 SECTION 2.11
Obligations Several. The obligations of the Lenders under the Loan Documents are several. The failure of any Lender or the Agent to carry out its obligations thereunder shall not relieve any other Lender or the Agent of any obligation
thereunder, nor shall any Lender or the Agent be responsible for the obligations of, or any action taken or omitted by, any other Person hereunder or thereunder. Nothing contained in any Loan Document shall be deemed to cause any Lender or the Agent
to be considered a partner of or joint venturer with any other Lender or Lenders, the Agent or the Company. 
 SECTION 2.12
Sharing. If any Lender shall obtain any payment (whether voluntary, involuntary, through the exercise of any right of set-off, or otherwise) on account of the Loans made by it (other than pursuant to a provision hereof providing for non-pro
rata treatment) in excess of its Pro Rata Share of payments on account of the Loans obtained by all the Lenders, such Lender shall forthwith purchase from the other Lenders, without recourse, such participations in the Loans made by them as shall be
necessary to cause such purchasing Lender to share the excess payment ratably with each of them in accordance with the respective Pro Rata Shares of the Lenders; provided, however, that if all or any portion of such excess payment is
thereafter recovered by or on behalf of the Company from such purchasing Lender, the purchase shall be rescinded and the purchase price restored to the extent of such recovery, but without interest. The Company agrees that any Lender so purchasing a
participation from another Lender pursuant to this Section 2.12 may exercise all its rights of payment (including the right of set-off) with respect to such participation as fully as if such Lender were the direct creditor of the Company
in the amount of such participation. No documentation other than notices and the like referred to in this Section 2.12 shall be required to implement the terms of this Section 2.12. 

  
 9 

 ARTICLE III 
 CONDITIONS PRECEDENT 
 SECTION 3.01 Conditions Precedent to the Loans. The
obligation of each Lender to make its Loan on the date of the borrowing hereunder (the “Closing Date”) shall be subject to the satisfaction of each of the following conditions precedent before or concurrently with the making of the
Loans: 
 (a) Fees and Expenses. The Company shall have paid all fees and expenses required to be paid pursuant to
Section 9.04; provided that the Agent shall have provided the Company with a detailed invoice at least two Business Days prior to the Closing Date. 
 (b) Loan Documents. The Agent shall have received the following Loan Documents executed by each of the respective parties thereto: 

(i) this Agreement; 
 (ii) any Notes required hereunder; and 
 (iii) the Security
Agreements. 
 (c) Documents and Actions Relating to Collateral. The Agent shall have received all financing statements
and other documents, instruments and agreements requested in writing by the Agent, which shall be necessary to create, in favor of the Agent for the benefit of the Lenders, a perfected Lien on the Collateral, subject to Permitted Liens. 

(d) Additional Closing Documents/Closing Deliverables. The Agent shall have received the following, executed by each of the
respective parties thereto: 
 (i) warrants substantially in the form attached hereto as Exhibit A.
Each warrant shall be exercisable at the time of the Company’s IPO or a Sale of the Company (if occurring prior to maturity) for the purchase of that number of shares of common stock of the Company as is equal to 15% of the original principal
amount of such Lender’s Loan divided by 70% of the value of such common stock in the Company IPO or such Sale of the Company, as applicable. The exercise price for shares purchased under the warrants shall be equal to 70% of the value of such
common stock in the Company IPO or such Sale of the Company, as applicable. 
 (ii) the Intercreditor Agreement;
and 
 (iii) a certificate of the Secretary or other appropriate officer of the Company, dated the Closing Date,
certifying (A) copies, certified, where appropriate, by the Secretary of State of the State of Delaware, of the Organic Documents of the Company and the resolutions and other actions taken or adopted by the Company authorizing the execution,
delivery and performance of the Loan Documents, and (B) the incumbency, authority and signatures of each 

  
 10 

 
officer of the Company authorized to execute and deliver the Loan Documents and act with respect thereto. 
 SECTION 3.02 Certain Additional Conditions Precedent to the Loans. The obligation of each Lender to make its Loan shall also be subject to the satisfaction of each of the following conditions
precedent: 
 (a) Representations and Warranties. On the date of the Loans, both before and after giving effect thereto
and to the application of proceeds therefrom: (i) the representations and warranties contained in Section 4.01 shall be true and correct in all material respects, except for any representation and warranty that is qualified by
materiality or reference to Material Adverse Effect, which representation and warranty shall be true and correct in all respects on and as of such date with the same effect as if made on and as of such date (except for any such representation and
warranty that by its terms is made only as of an earlier date, which representation and warranty shall remain true and correct in all material respects as of such earlier date, except for any representation and warranty that is qualified by
materiality or reference to Material Adverse Effect, which representation and warranty shall be true and correct in all respects as of such earlier date). 
 (c) No Default. No Default shall have occurred and be continuing or shall result from the making of the Loans. 
 ARTICLE IV 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 

SECTION 4.01 Representations and Warranties. The Company represents and warrants to the Agent and the Lenders that: 

(a) Organization and Powers. The Company is duly organized or formed, as the case may be, validly existing and in good standing
under the laws of the State of Delaware. The Company is qualified to do business and is in good standing in each jurisdiction in which the failure so to qualify or be in good standing would result in a Material Adverse Effect. 

(b) Authorization; No Conflict. The execution, delivery and performance by the Company of the Loan Documents have been duly
authorized by all necessary action of the Company and do not and will not, to the best of the Company’s knowledge, (i) contravene the terms of the Organic Documents of the Company; (ii) result in a breach of or constitute a default
under any material lease, instrument, contract or other agreement to which the Company is a party or by which it or its properties may be bound or affected, except where such breach or default could not reasonably be expected to have a Material
Adverse Effect; or (iii) violate any provision of any law, rule, regulation, order, judgment, decree or the like binding on or affecting the Company, except where such violation could not reasonably be expected to have a Material Adverse
Effect. 

  
 11 

 (c) Binding Obligation. The Loan Documents constitute, or when delivered under this
Agreement will constitute, legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization,
moratorium, or similar debtor relief laws from time to time in effect which affect the enforcement of creditors’ rights in general and the availability of equitable remedies. 

(d) Litigation. As of the Closing Date, there are no actions, suits or proceedings pending or, to the best of the Company’s
knowledge, threatened against or affecting the Company before any governmental agency or authority or arbitrator which if determined adversely to the Company would result in a Material Adverse Effect. 

(e) Financial Statements. All financial statements of the Company delivered to the Agent on or prior to the Closing Date are
complete and correct in all material respects and fairly present the financial condition of the Company as at the times and for the periods covered by such statements, in each case in accordance with GAAP, subject, in the case of any unaudited
financial statements, to normal yearend adjustments and any absence of notes, except as otherwise amended, restated, supplemented or otherwise subsequently modified by the Company on or prior to the Closing Date. 

(f) Taxes. As of the Closing Date, the Company has duly filed all tax returns required to be filed, and has paid all
taxes, fees, assessments and other governmental charges or levies that have become due and payable, except to the extent such taxes or other charges are being contested in good faith and are adequately reserved against in accordance with GAAP;
provided that the failure to file tax returns or to pay taxes shall not constitute a breach of this representation and warranty unless the aggregate amount of taxes relating thereto could reasonably be expected to exceed $100,000. 

(g) Insurance. The properties of the Company are insured in such amounts, with such deductibles and covering such risks as is
customarily carried by companies engaged in similar businesses and owning similar properties in the localities where the Company operates as determined by the Company in its sole discretion. 

(h) Compliance With Laws. As of the Closing Date, the Company is in compliance with all material laws, rules, regulations, orders
and decrees which are applicable to it or its properties, except where the failure to be in compliance could not reasonably be expected to result in a Material Adverse Effect. Without limiting the generality of the foregoing, as of the Closing Date,
the Company is in material compliance with all Environmental Laws, and there are no actions, suits, claims, notices of violation, hearings, investigations or proceedings pending or, to the best of the Company’s knowledge, threatened against or
affecting the Company or with respect to the ownership, use, maintenance and operation of the Company’s properties, relating to any Environmental Laws, where any adverse determination with respect thereto or liability imposed therein could
reasonably be expected to result in a Material Adverse Effect. 

  
 12 

 ARTICLE V 
 COVENANTS 
 SECTION 5.01 Reporting Covenants. So long as any of the
Obligations shall remain unpaid, the Company agrees that: 
 (a) Financial Statements and Other Reports. The Company will
furnish to the Agent: (i) no later than 120 days after and as of the end of each fiscal year, the Company’s annual financial statements for such fiscal year; and (ii) simultaneously with the delivery of the financial statements
referred to in clause (i), a certificate of a Responsible Officer of the Company in form and substance reasonably satisfactory to the Agent stating whether any Event of Default exists on the date of such certificate, and if so, setting forth the
details thereof and the action which the Company is taking or proposes to take with respect thereto (which delivery may be by electronic communication including fax or email and shall be deemed to be an original authentic counterpart thereof for all
purposes). 
 (b) Additional Information. The Company will furnish to the Agent: (i) promptly after the Company has
knowledge or becomes aware thereof, notice of the occurrence of any Event of Default; (ii) prompt written notice of all actions, suits and proceedings before any governmental agency or authority or arbitrator pending, or to the best of the
Company’s knowledge, threatened against or affecting the Company, including any actions, suits, claims, notices of violation, hearings, investigations or proceedings pending, or to the best of the Company’s knowledge, threatened against or
affecting the Company, or with respect to the ownership, use, maintenance and operation of their respective properties, relating to Environmental Laws, which could reasonably be expected to result in a Material Adverse Effect; and (iii) prompt
written notice of any other condition or event which has resulted, or that could reasonably be expected to result, in a Material Adverse Effect. 
 SECTION 5.02 Affirmative Covenants. So long as any of the Obligations shall remain unpaid, the Company agrees that: 
 (a) Preservation of Existence, Etc. The Company will maintain and preserve its legal existence, its rights to transact business and all other rights, franchises and privileges necessary or
desirable in the normal course of its business and operations and the ownership of its properties, except in connection with any transactions not expressly prohibited hereunder. 

(b) Payment of Taxes. The Company will pay and discharge all material taxes, fees, assessments and governmental charges or levies
imposed upon it or upon its properties or assets prior to the date on which penalties attach thereto, and all lawful claims for labor, materials and supplies which, if unpaid, might become a Lien upon any properties or assets of the Company, except
to the extent such taxes, fees, assessments or governmental charges or levies, or such claims, are being contested in good faith by appropriate proceedings and are adequately reserved against in accordance with GAAP; provided that the

  
 13 

 
failure to make any such payments shall not constitute a breach of this covenant unless the aggregate amount of such payments could reasonably be expected to exceed $200,000. 

(c) Maintenance of Insurance. The Company will (i) carry and maintain in full force and effect insurance in such amounts,
with such deductibles and covering such risks as is customarily carried by companies engaged in the same or similar businesses and owning similar properties in the localities where the Company operates as determined by the Company in its sole
discretion and (ii) if requested by the Agent in writing, promptly provide the Agent with such evidence as it reasonably requests to demonstrate compliance with this Section 5.02(c), including delivering to the Agent a report from
the Company’s insurance broker regarding the adequacy of the Company’s insurance; provided, however, that (x) if the Agent requests such evidence that would require the Company to pay or incur additional fees and/or
expenses in excess of the fees and expenses historically paid by the Company with respect to insurance as determined by the Company in its sole discretion, then the Company shall inform the Agent of such additional fees and/or expenses and
(y) if the Agent requests such evidence after being informed of such additional fees and/or expenses, then such additional fees and/or expenses shall be paid by the Agent. 

(d) Keeping of Records and Books of Account. The Company will keep adequate records and books of account, in which entries will be
made in accordance with GAAP. 
 (e) Inspection Rights. Upon ten Business Days’ prior written notice, the Company
will, at any reasonable time during normal business hours and from time to time, permit the Agent or any of its agents or representatives to examine the records and books of account of the Company. 

(f) Compliance with Laws, Etc. The Company will comply in all material respects with the requirements of all applicable material
laws, rules, regulations and orders of any governmental agency or authority, including all Environmental Laws and ERISA, and the terms of any contract or other instrument to which it may be a party or under which it may be bound. 

(g) Maintenance of Properties, Etc. The Company will maintain and preserve all of its material properties necessary or useful in
the proper conduct of its business in good working order and condition in accordance with the general practice of other Persons of similar character and size, ordinary wear and tear excepted. 

(h) Licenses. The Company will obtain and maintain all material licenses, authorizations, consents, filings, exemptions,
registrations and other governmental approvals of any governmental agency or authority necessary for the operation and conduct of its business. 
 (i) Observer Rights. From the Closing Date until the earlier to occur of (i) the closing of the Company IPO or (ii) the closing of a Sale of the Company, the Company will allow the
Lenders to have the right to appoint one individual to attend meetings of the Company’s Board of 

  
 14 

 
Directors as an observer; provided that such individual shall be reasonably acceptable to the Company; and provided, further, that notwithstanding the foregoing provisions of
this Section 5.02(i), such observer may be excluded from any meeting or receiving any information, but only to the extent necessary or appropriate (A) to protect any confidential matters discussed therein, (B) to protect the
Company’s attorney/client privilege or (C) in the event that the Company’s Board of Directors reasonably determines in good faith that such observer has a conflicting interest. 

(j) Minimum Cash Balance. From the Closing Date until the date that the Indebtedness of the Company owed to Point has been paid in
full, the Company and its Subsidiaries, on a consolidated basis, will maintain a cash balance at all times in an amount equal to or greater than the lesser of (i) $5,000,000 and (ii) the outstanding Indebtedness of the Company owed to
Point. 
 SECTION 5.03 Negative Covenants. So long as any of the Obligations shall remain unpaid, the Company agrees
that: 
 (a) Indebtedness. The Company will not create, incur, assume or otherwise become liable for or suffer to exist
any Indebtedness, other than: 
 (i) Indebtedness of the Company to the Lenders or the Agent hereunder;

 (ii) Indebtedness of the Company existing on the Closing Date and disclosed on Schedule 2 and
extensions, renewals and refinancings of such Indebtedness, provided that (x) such Indebtedness has been disclosed on the most recent financial statements of the Company submitted to the Agent or any Lender on or prior to the date of
this Agreement, and (y) the principal amount of such Indebtedness is not increased except by an amount equal to a reasonable premium or other reasonable amount paid, and fees and expenses reasonably incurred, in connection with such extension,
renewal or refinancing and by an amount equal to any existing unused commitments thereunder; 

(iii) unsecured trade, utility or non-extraordinary accounts payable arising in the ordinary course of business;

 (iv) [intentionally omitted]; 

(v) Purchase Money Indebtedness; provided that the material terms and conditions of any Purchase Money Indebtedness
relating to the Michigan Facility shall have been (x) disclosed to the Agent prior to the Company’s incurrence of such Indebtedness such that the Agent is provided with reasonably sufficient time to review such terms and conditions prior
to the Company becoming obligated to incur such Indebtedness, and (y) consented to in writing by the Agent (such consent not to be unreasonably withheld, delayed or conditioned); 

(vi) cash management agreements in the ordinary course of business; 

(vii) Indebtedness arising from judgments or decrees in an aggregate principal amount outstanding at any time not to
exceed $100,000; 
 (viii) sales rebates issued by the Company to customers in the ordinary course of business;

  
 15 

 (ix) grants provided by the United States government in exchange for the
Company’s obligation to purchase equipment specified by such grants or to fund research and development efforts specified in such grants; 
 (x) Indebtedness owed to the lenders pursuant to that certain Loan Agreement with respect to the Convertible Note Financing October 2012; 

(xi) Indebtedness that is incurred on the date of the consummation of a Permitted Acquisition solely for the purpose of
consummating such Permitted Acquisition so long as no Event of Default has occurred and is continuing or would result therefrom; 
 (xii) Acquired Indebtedness; 
 (xiii) Indebtedness consisting of
guarantees resulting from endorsement of negotiable instruments for collection by the Company in the ordinary course of business; 
 (xiv) interest rate swaps, currency swaps and similar financial products entered into or obtained in the ordinary course of business; 

(xv) Subordinated Debt; 
 (xvi) Indebtedness of the Company to any of its wholly owned Subsidiaries; 
 (xvii) Indebtedness of the Company pursuant to a working capital facility secured by a first priority security interest in the Company’s Accounts (as such term is defined in the Code) and Inventory
(as such term is defined in the Code); and 
 (xviii) additional Indebtedness of the Company not otherwise
described above in an aggregate principal amount not to exceed $2,000,000 at any time outstanding. 
 (b) Liens. The
Company will not create, incur, assume or suffer to exist any Lien upon or with respect to any of its properties, revenues or assets, whether now owned or hereafter acquired, other than the following (such Liens, collectively, “Permitted
Liens”): 
 (i) Liens in favor of the Lenders or the Agent; 

(ii) the existing Liens listed in Schedule 3 or incurred in connection with the extension, renewal or
refinancing of the Indebtedness secured by such existing Liens, provided that any extension, renewal or replacement Lien shall be limited to the property encumbered by the existing Lien and the principal amount of the Indebtedness being
extended, renewed or refinanced does not increase; 
 (iii) Liens for taxes, fees, assessments or other
governmental charges or levies (A) not yet due or as to which the period of grace, if any, related thereto has not expired, or (B) which are being contested in good faith by appropriate proceedings and which are adequately reserved for in
accordance with GAAP; 
 (iv) Liens securing Indebtedness permitted by Section 5.03(a)(v);

  
 16 

 (v) attachments, judgments, and other similar Liens arising in connection
with court proceedings; provided, however, that the execution or other enforcement of such Liens is effectively stayed and claims secured thereby are being actively contested in good faith by appropriate proceedings; 

(vi) Liens of materialmen, mechanics, warehousemen, repairmen, carriers or employees or other similar Liens provided
for by mandatory provisions of law (A) which are not filed or recorded for a period of more than sixty days, or (B) which are being contested in good faith by appropriate proceedings and which are adequately reserved for in accordance with
GAAP; 
 (vii) pledges or deposits made or Liens in incurred in the ordinary course of business in connection
with workers’ compensation, unemployment insurance and other social security or employment or insurance legislation; 
 (viii) Liens consisting of deposits or pledges to secure the performance of bids, trade contracts, leases, public or statutory obligations, or other obligations of a like nature incurred in the
ordinary course of business; 
 (ix) easements, rights-of-way, restrictions and other similar encumbrances
affecting real property which, in the aggregate, do not materially detract from the value of the property subject thereto or materially interfere with the ordinary conduct of the business of the Company; 

(x) Liens arising from precautionary UCC financing statements regarding operating leases; 

(xi) Liens in favor of financial institutions in the ordinary course of business in connection with, and which solely
encumber, deposit, disbursement or concentration accounts maintained with such financial institutions on funds and other items in such accounts; 
 (xii) Liens solely on any cash earnest money deposits made by the Company in connection with any letter of intent or purchase agreement with respect to a Permitted Acquisition; 

(xiii) Liens assumed by the Company in connection with a Permitted Acquisition that secure Acquired Indebtedness;

 (xiv) Liens securing Indebtedness permitted pursuant to Section 5.03(a)(x); 

(xv) Liens securing Indebtedness permitted pursuant to Section 5.03(a)(xv); 

(xvi) Liens securing Indebtedness permitted pursuant to Section 5.03(a)(xvii); 

(xvii) Liens securing Indebtedness under the Convertible Note Financing October 2012; and 

(xviii) other Liens securing obligations in an aggregate amount not to exceed $2,000,000. 

  
 17 

 (c) Accounting Methods. The Company will not change (i) the times of
commencement or termination of its fiscal year or (ii) its methods of accounting, in each case, except as required by GAAP. 
 (d) Name Change. The Company will not change its name unless the Company has provided at least 2 days’ prior written notice to the Agent of such change. 

ARTICLE VI 

EVENTS OF DEFAULT 
 SECTION 6.01 Events of Default. Any of the following events which shall occur shall constitute an “Event of Default”: 

(a) Payments. Immediately and without notice from the Agent or any Lender upon the Company’s failure to pay when due any
principal, interest or other charges or expenses that the Company is required to pay pursuant to this Agreement or the other Loan Documents; provided, however, that Company shall have the right to cure such Event of Default by paying the full amount
of such payment in accordance with this Agreement within thirty days following such failure. 
 (b) Representations and
Warranties. Any representation or warranty by the Company under or in connection with the Loan Documents shall prove to have been incorrect in any material respect when made or deemed made. 

(c) Failure by Company to Perform Covenants. The Company shall fail to perform or observe any covenant or agreement contained in
any Loan Document on its part to be performed or observed and any such failure continues uncured for a period of thirty days after the Company receives written notice of such failure from the Agent. 

(d) Voluntary Proceedings. The Company (i) generally fails to pay, or admits in writing its inability to pay, its debts as
they become due, subject to applicable grace periods, if any, whether at stated maturity or otherwise; (ii) voluntarily ceases to conduct its business in the ordinary course; (iii) commences any Insolvency Proceeding with respect to
itself; or (iv) takes any action to effectuate or authorize any of the foregoing. 
 (e) Involuntary Proceedings.
(i) Any involuntary Insolvency Proceeding is commenced or filed against the Company, or any writ, judgment, warrant of attachment, execution or similar process, is issued or levied against a substantial part of such Person’s properties,
and any such proceeding or petition shall not be dismissed, or such writ, judgment, warrant of attachment, execution or similar process shall not be released, vacated or fully bonded within sixty days after commencement, filing or levy;
(ii) the Company admits the material allegations of a petition against it in any Insolvency Proceeding, or an order for relief (or similar order under non-U.S. law) is ordered in any Insolvency Proceeding; or (iii) the Company acquiesces
in the appointment of a receiver, trustee, custodian, conservator, liquidator, mortgagee in 

  
 18 

 
possession (or agent therefor), or other similar Person for itself or a substantial portion of its property or business. 
 (f) Dissolution, Etc. The Company shall (i) liquidate, wind up or dissolve (or suffer any liquidation, wind-up or dissolution), except in connection with any Sale of the Company,
(ii) suspend its operations other than in the ordinary course of business, or (iii) take any action to authorize any of the actions or events set forth above in this subsection (f). 

(g) [Intentionally Omitted]. 
 (h) Collateral Documents. The Company or any other Person shall fail to perform or observe in any material respect any term, covenant or agreement contained in the Collateral Documents on its part
to be performed or observed and any such failure shall remain unremedied beyond the grace period, if any, specified therein, or any “Event of Default” as defined in any Collateral Document shall have occurred; or any of the Collateral
Documents after delivery thereof shall for any reason be revoked or invalidated, or otherwise cease to be in full force and effect, or any of the Collateral Documents for any reason, except to the extent permitted by the terms thereof, shall cease
to create a valid and perfected Lien subject only to Permitted Liens in any of the Collateral purported to be covered thereby. 

SECTION 6.02 Effect of Event of Default. If any Event of Default shall occur and be continuing beyond any cure period provided
for in this Agreement with respect to such Event of Default, the Agent may (i) by notice to the Company, (A) declare the Commitments of the Lenders to be terminated, whereupon the same shall forthwith terminate, and (B) declare the
entire unpaid principal amount of the Loans and any Notes, all interest accrued and unpaid thereon and all other Obligations, including without limitation, (subject only to any limitation imposed by applicable law) all out-of-pocket expenses,
including, without limitation, attorneys’ fees and legal expenses, incurred by any Lender in endeavoring to collect any amounts payable hereunder which are not paid when due, whether by acceleration or otherwise, all of which expenses shall be
deemed added to the Obligations immediately upon the occurrence of an Event of Default, to be forthwith due and payable, whereupon the Loans and any Notes, all such accrued interest and all such other Obligations shall become and be forthwith due
and payable, without presentment, demand, protest or further notice of any kind, all of which are hereby expressly waived by the Company, provided that upon the occurrence of an actual or deemed entry of an order for relief with respect to
the Company under the Bankruptcy Code, the result which would otherwise occur only upon giving of notice by the Agent to the Company as specified in this clause (i) shall occur automatically, without the giving of any such notice; and
(ii) whether or not the actions referred to in clause (i) have been taken, (A) exercise any or all of the Lenders’ and/or the Agent’s rights and remedies under the Collateral Documents, and (B) proceed to enforce all
other rights and remedies available to the Lenders and the Agent (acting on behalf of the Lenders) under the Loan Documents and applicable law. 

  
 19 

 ARTICLE VII 
 THE AGENT 
 SECTION 7.01 Appointment. Each Lender hereby irrevocably
designates and appoints the Agent as the Agent of such Lender under the Loan Documents and each such Lender hereby irrevocably authorizes the Agent, as the Agent for such Lender, to take such action on its behalf under the provisions of the Loan
Documents and to exercise such powers and perform such duties as are expressly delegated to the Agent by the terms of the Loan Documents, together with such other powers as are reasonably incidental thereto. 

SECTION 7.02 Delegation of Duties. The Agent may execute any of its duties under the Loan Documents by or through agents or
attorneys-in-fact and shall be entitled to advice of counsel concerning all matters pertaining to such duties. 

SECTION 7.03 Successor Agent. The Agent may resign as Agent under the Loan Documents upon thirty days’ prior
written notice to the Company and the Lenders representing the majority by dollar value of the outstanding principal amount of the Loans hereunder (the “Majority Lenders”). If the Agent shall resign, then the Lenders shall appoint a
successor Agent, subject to the right of the Company to approve the successor Agent, which approval shall not be unreasonably withheld, delayed or conditioned, whereupon such successor Agent shall succeed to the rights, powers and duties of the
Agent, and the term “Agent” shall mean such successor Agent effective upon its appointment, and the former Agent’s rights, powers and duties as Agent shall be terminated, subject only to such former Agent’s right to be
compensated in the amount of such portion of the Administrative Agency Fee as shall be equal to the portion of the time which shall have elapsed between the Closing Date and the date upon which the Administrative Agency Fee shall have become due and
payable in accordance with Section 2.05, during which time such former Agent served as Agent under the Loan Documents, without any other or further act or deed on the part of such former Agent or any of the parties to this Agreement or
any of the Loan Documents or successors thereto; provided that in no event shall the former Agent be compensated prior to the Applicable Maturity Date. After any retiring Agent’s resignation hereunder as Agent, the provisions of this
Section 7.03 (including the rights of such former Agent to proportional compensation from the Administrative Agency Fee as set forth herein) shall inure to its benefit as to any actions taken or omitted to be taken by it while it was
Agent under the Loan Documents. 
 SECTION 7.04 Authorization to the Agent. Each Lender hereby authorizes the Agent
to take such action as agent on its behalf and to exercise such powers and perform such duties under this Agreement and the Notes as are delegated to the Agent by the terms hereof or thereof, together with such powers as are reasonably incidental
thereto. The duties and obligations of the Agent are strictly limited to those expressly provided for herein, and no implied covenants, functions, responsibilities, duties, obligations or liabilities shall be read into this Agreement or otherwise
exist against the Agent. The Agent is hereby authorized on behalf of each of the Lenders to: (a) exercise or refrain from exercising any rights, remedies or powers of the Lenders under applicable law in respect of the Loan Documents or all or
any portion of any Collateral, (b) sell, release, surrender, realize upon, substitute or otherwise deal with, in any manner and in any order, all or any portion of any Collateral, (c) make any demands or give any notices under or in
connection with the Notes, the Loan Documents and this Agreement, (d) effect amendments to and grant waivers under the Loan Documents, including without limitation, this Agreement and any Security Agreement, (e) distribute payments to the
Lenders of amounts paid to it by the Company or received by it in connection with the Collateral, (f) receive and hold on behalf of the Lenders any instruments or other possessory Collateral, (g) exercise rights of conversion under the
Notes and distribute corporate stock or partnership units among the Lenders in proportion to their investment, and (h) engage, replace, instruct and remunerate on behalf of the Lenders consultants,

  
 20 

 
experts, counsel and other persons to be engaged by the Agent or the Lenders, including legal counsel for Agent or the Lenders. As to the exercise of any of its powers and discharge of any of its
duties, the Agent shall be entitled, but shall not be required, to obtain instructions of the Majority Lenders, and shall be fully protected in acting or refraining from acting upon such instructions and such instructions, if any, shall be binding
upon all Lenders. Except for actions expressly required of the Agent hereunder, the Agent shall in all cases be fully justified in failing or refusing to act under this Agreement and the Notes and other Loan Documents unless it shall be indemnified
to its satisfaction by the Lenders against any and all liability and expense which may be incurred by reason of taking or continuing to take any such action, and the Agent shall not in any event be required to take any action which exposes the Agent
to liability or which is contrary to this Agreement, the Loan Documents, the Notes or applicable law. Each Lender hereby agrees with the other Lenders that it shall not seek to exercise remedies of a secured party hereunder except through the Agent.

 SECTION 7.05 Apparent Authority. The Company acknowledges the authority granted to the Agent by the Lenders and
shall be permitted to rely exclusively, without further investigation, upon the representations, consents, waivers and all other actions taken by the Agent. The Company, for itself and its affiliates and their successors and assigns, hereby
acknowledges that at all times prior to the execution and delivery by the Agent of this Agreement, the Company has accepted and relied upon, and will continue to accept and rely upon the actual and apparent authority of the Agent acting alone and
without further authorization from the Lenders or any of them, with respect to any or all of the rights, powers, authority or remedies granted or reserved to the Agent or the Lenders, the Loan Documents, or the Notes or any of them. The Company
acknowledges and agrees that the Agent has all right and apparent and actual authority to exercise alone the rights, powers, and remedies granted or reserved to the Agent or the Lenders under this Agreement, the Notes and the Loan Documents without
further evidence of such authority or confirmation thereof from or by any Lender. 
 (a) Substitution of Collateral. The
Company acknowledges and agrees that the Agent has all necessary and sufficient authority, acting alone, to agree to the terms of this Agreement, including without limitation, the substitution of all loan or credit interests, including without
limitation any perfected security interests granted by the Company or its affiliates, for the equity interests which are the subject of the conversion provisions set forth in this Agreement or in the Notes or other Loan Documents, whether such
substituted equity interests are represented by partnership interests or by common or preferred stock interests in the Company, or its affiliates, successors or assigns. 
 (b) Allocation of Loan Payments. The Company acknowledges and agrees that the Agent has the all necessary and sufficient right and authority, acting alone to allocate any and all payments made by
the Company to any of the outstanding loan balances which shall be or become due from the Company in accordance with this Agreement, the Notes, or any of the Loan Documents. The Company agrees that the Agent may apply any and all payments made
pursuant this Agreement, the Notes, or any of the Loan Documents to any outstanding obligation of the Company to the Lenders or any of them in the manner the Agent, in his absolute discretion, sees fit, regardless of whether such allocation would or
might have the effect of creating a breach or Default or Event of Default under any of this Agreement, the Notes, or any of the Loan Documents. 
 ARTICLE VIII 
 REPRESENTATIONS AND WARRANTIES OF THE LENDERS 

SECTION 8.01 Representations and Warranties 

  
 21 

 SECTION 8.02 of the Lenders. Each Lender represents and warrants to the
Company, severally and not jointly, with respect to its Note and any equity securities issuable upon any conversion of its Note, as follows: 
 (a) High Risk Investment. Such Lender is experienced in evaluating and investing in companies with similar financial concerns as those of the Company and understands the high risk nature of such
Lender’s investment. 
 (b) Accredited Investor. Such Lender (i) is an “accredited” investor as
defined under U.S. federal securities laws and (ii) has such knowledge and experience in financial and business matters that such Lender is capable of evaluating the merits and risks of such investment, is able to incur a complete loss of such
investment and is able to bear the economic risk of such investment for an indefinite period of time. Notwithstanding the foregoing and subject to compliance with applicable securities laws, the Company may consent in writing to allowing a Person to
be a Lender under this Agreement even if such Person cannot make the representations and warranties set forth in clause (b)(i) of this Section 8.01. 
 (c) Investment. Such Lender is acquiring its Note and any equity securities issuable upon any conversion of such Note for investment for such Lender’s own account, not as a nominee or agent,
and not with the view to, or for resale in connection with any distribution thereof. Such Lender understands that its Note to be issued to it and any equity securities issuable upon any conversion of such Note have not been, and will not be,
registered under the Securities Act of 1933, as amended (the “Securities Act”) by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of
the investment intent and the accuracy of such Lender’s representations as expressed herein. 
 (d) Rule 144. Such
Lender acknowledges that its Note to be issued to it and any equity securities issuable upon any conversion of such Note must be held indefinitely unless subsequently registered under the Securities Act or an exemption from such registration is
available. Such Lender is aware of the provisions of Rule 144 promulgated under the Securities Act which permit limited resale of shares purchased in a private placement subject to the satisfaction of certain conditions, including, among other
things, the existence of a public market for the shares, the availability of certain current public information about the Company, the resale occurring not less than one year after a party has purchased and paid for the security to be sold, the sale
being effected through a “broker’s transaction” or in transactions directly with a “market maker” (as provided by Rule 144(f)) and the number of shares being sold during any three-month period not exceeding specified
limitations. 
 (e) No Public Market. Such Lender understands that no public market now exists for any of the securities
issued by the Company and that there is no assurance that a public market will ever exist for the Notes or the equity securities issuable upon conversion of the Notes. 
 (f) Access to Data. Such Lender has had an opportunity to discuss the Company’s business and financial affairs with its management. Such Lender understands that such discussions, as well as
any written information issued by the Company, were intended to describe the aspects of the Company’s business and prospects which it believes to be material but were not necessarily a thorough or exhaustive description. Such Lender
acknowledges that any estimates or projections as to events that may occur in the future are based upon the best judgment of the Company’s management as of the date of this Agreement. Whether or not such estimates or projections may be achieved
will depend upon the Company achieving its overall business objectives. There is no guarantee that any of these projections will be attained. Such Lender acknowledges that as part of the opportunity to investigate the Company’s affairs, such
Lender has been provided with the Company’s website address: https://marronebio.com, and 

  
 22 

 
access to a ShareFile Account maintained by the Company (https://marronebio.sharefile.com/) containing, inter alia, copies of the financial statements of the Company for the immediately
preceding three (3) fiscal years, copies of loan documents representing the prior and existing indebtedness of the Company as disclosed on Schedule 2 of this Agreement, copies of summaries prepared for the purpose of acquainting investors with
the business operations and prospects of the Company, an appraisal of the Michigan Facility and other data deemed pertinent by the Company to a reasonable portrayal of its financial and business affairs. 

ARTICLE IX 

MISCELLANEOUS 

SECTION 9.01 Amendments and Waivers. Except as otherwise provided herein or in any other Loan Document, (i) no amendment to
any provision of this Agreement or any of the other Loan Documents shall in any event be effective unless the same shall be in writing and signed by the Company and the Agent; and (ii) no waiver of any provision of this Agreement or any other
Loan Document, or consent to any departure by the Company or other party therefrom, shall in any event be effective unless the same shall be in writing and signed by the Agent and the Company. Any such amendment, waiver or consent shall be effective
only in the specific instance and for the specific purpose for which given; provided, however, that, notwithstanding the foregoing provisions of this Section 9.01, any term or provision of any such other Loan Document may
be amended without the agreement or consent of, or prior notice to, any party hereto, to the extent such Loan Document provides for amendments without the agreement or consent of, or notice to, such party. 

Notwithstanding any provision herein to the contrary, this Agreement may be amended with the written consent of the Agent and the Company
to add one or more additional term loan facilities to this Agreement, and to permit the extensions of credit and all related obligations and liabilities arising in connection therewith from time to time outstanding to share ratably (or on a basis
subordinated to the existing facilities hereunder) in the benefits of this Agreement and the other Loan Documents with the obligations and liabilities from time to time outstanding in respect of the existing facilities hereunder. 

SECTION 9.02 Notices. All notices and other communications provided for hereunder and under the other Loan Documents shall,
unless otherwise stated herein, be in writing (including by facsimile transmission and by electronic mail) and mailed (by certified or registered mail), sent or delivered to the respective parties hereto at or to their respective addresses or
facsimile numbers set forth below their names on the signature pages hereof, or at or to such other address, facsimile number or email address as shall be designated by any party in a written notice to the other party hereto. All such notices and
communications shall be effective (i) if delivered by hand, sent by certified or registered mail or sent by an overnight courier service, when received; and (ii) if sent by facsimile transmission or electronic mail, when sent. Electronic
mail may be used only for routine communications, such as financial statements and other information documents, and to distribute Loan Documents for execution by the parties thereto, and may not be used for any other purpose. 

SECTION 9.03 No Waiver; Cumulative Remedies. No failure on the part of any Lender to exercise, and no delay in exercising, any
right, remedy, power or privilege under any Loan Document shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, remedy, power or privilege preclude any other or further exercise thereof or the exercise of any
other right, remedy, power or privilege. The rights and remedies 

  
 23 

 
under the Loan Documents are cumulative and not exclusive of any rights, remedies, powers and privileges that may otherwise be available to the Lenders. 

SECTION 9.04 Fees and Disbursements of Counsel. The Company agrees to pay on demand the reasonable fees and
disbursements of one special counsel for the Lenders in connection with the negotiation, preparation, execution, and delivery of the Loan Documents in an amount not to exceed (a) $25,000 minus (b) the fees and disbursements of one
special counsel for the Lenders in connection with the negotiation, preparation, execution, and delivery of the documents relating to the Convertible Note Financing October 2012; provided that (x) in no event shall the Agent or any
Lender deduct such fees and disbursements of counsel from the Loans and (y) Agent shall promptly provide the Company with a detailed invoice of such fees and disbursements of counsel upon request thereof. 

SECTION 9.05 Survival. All covenants, agreements, representations and warranties made in any Loan Documents shall, except to the
extent otherwise provided therein, survive the execution and delivery of this Agreement, the making of the Loans and the execution and delivery of any Notes, and shall continue in full force and effect so long as any Lender has any Commitment, the
Loans shall remain outstanding or any other Obligations remain unpaid or any obligation to perform any other act hereunder or under any other Loan Document remains unsatisfied. 

SECTION 9.06 Benefits of Agreement. The Loan Documents are entered into for the sole protection and benefit of the parties hereto
and their successors and assigns, and no other Person shall be a direct or indirect beneficiary of, or shall have any direct or indirect cause of action or claim in connection with, any Loan Document. 

SECTION 9.07 Binding Effect; Assignment. 
 (a) Binding Effect. This Agreement shall become effective when it shall have been executed by the Company, the Lenders, and the Agent, and thereafter shall be binding upon, inure to the benefit of
and be enforceable by the Company, each Lender, the Agent, and their respective successors and assigns. 
 (b)
Assignment. The Company shall not have the right to assign its rights and obligations hereunder or under the other Loan Documents or any interest herein or therein without the prior written consent of the Agent, except in connection with an
assignment in whole to a successor to the Company; provided that such successor acquires all or substantially all of the assets or equity of the Company and the Agent’s and the Lenders’ rights hereunder are not materially impaired.
Each Lender may sell, assign or transfer all or any portion of such Lender’s rights and obligations hereunder and under the other Loan Documents to any Lender or other Person on the basis set forth below in this subsection (b) and subject
to compliance with applicable securities laws. 
 (i) Any Lender may, with the written consent of the Company, at any time and
from time to time, assign and delegate to one or more Persons all, or any ratable part, of such Lender’s Loan, its Commitment and the other rights and obligations of such Lender hereunder; provided, however, that no written
consent of the Company shall be required during the existence of a Default or in 

  
 24 

 
connection with any assignment and delegation by a Lender to another Lender or an Affiliate of such Lender; and (ii) except in connection with an assignment of all of a Lender’s rights
and obligations with respect to its Commitment and Loan, any such assignment to any Person that is not a Lender hereunder shall be equal to or greater than $1,000,000. 
 (ii) In the event of any such assignment, unless and until an assignment and assumption agreement (an “Assignment and Assumption”) and notice of assignment shall have been delivered by
the assigning Lender and the assignee to the other Lenders and the Company (unless waived in writing by the Agent and the Company), such assignee shall not be entitled to exercise the rights of a Lender under this Agreement and the other Loan
Documents with respect to such assignment and the Company shall not be obligated to make payment of any amount to which such assignee may become entitled thereunder other than to the assigning Lender. Subject to satisfaction of the foregoing
conditions in connection with any assignment, upon the effectiveness of such assignment the assignee shall be deemed a “Lender” for all purposes of this Agreement and the other Loan Documents with respect to the rights and obligations
assigned to it, and the other Loan Documents with respect to the rights and obligations assigned to it, and the assigning Lender shall, to the extent that rights and obligations hereunder and under the other Loan Documents have been assigned by it
pursuant to such Assignment and Assumption, relinquish its rights and be released from its obligations under the Loan Documents. 
 (iii) In connection with any partial assignment, upon the written request of the assigning Lender, the Agent, or the assignee, (A) the Company shall execute and deliver substitute Notes to the
assigning Lender or the assignee, dated the effective date of such assignment, setting forth the principal amount of the Loans held by such assigning Lender and assignee (after giving effect to the assignment), and containing other appropriate
insertions, and the assigning Lender shall thereupon return the Note previously held by it; and (B) Schedule 1 shall be deemed amended to reflect the adjustment of the Commitments and Pro Rata Shares of the Lenders resulting therefrom.

 (iv) The Company agrees that in connection with any such grant or assignment, the Agent or such Lender may deliver to the
prospective assignee financial statements and other relevant information relating to the Company. 
 (v) The Agent or each
Lender shall obtain from any such prospective assignee a confidentiality agreement in which such assignee agrees to an obligation of confidentiality substantially similar to the terms of Section 9.08. 

SECTION 9.08 Confidentiality. The Agent and each Lender shall hold all nonpublic information relating to the Company and its
Subsidiaries obtained by it under this Agreement in accordance with its customary procedures for handling confidential information of this nature, except for: (i) disclosure to it, its Affiliates and their respective directors, officers,
employees, agents and representatives in connection with the negotiation, execution or performance of the Loan Documents; (ii) disclosure as reasonably required in connection with a transfer to a prospective assignee of all or part of its Loan,
as provided in Section 9.07; (iii) disclosure as may be required or requested by any governmental agency or authority or representative thereof or pursuant to legal process; (iv) disclosure to any Person and in any proceeding
necessary in such Person’s judgment to protect its interests in connection with any claim or dispute involving such Person; and (v) any other disclosure with the prior written consent of the Company. Prior to any disclosure by the Agent or
any Lender of such nonpublic information permitted under clause (iii), it shall, if permitted by applicable laws or judicial order, notify the Company of such pending disclosure. Upon the Company’s written request, the Agent and the Lenders
shall promptly return any materials furnished by the Company or its Subsidiaries. Notwithstanding the foregoing, such obligation of 

  
 25 

 
confidentiality shall not apply if the information or substantially similar information is or becomes part of the public domain. 

SECTION 9.09 Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF
CALIFORNIA. 
 SECTION 9.10 Submission to Jurisdiction. The Company, the Lenders, and the Agent each hereby
(i) submits to the nonexclusive jurisdiction of the courts of the State of California and the Federal courts of the United States sitting in the State of California for the purpose of any action or proceeding arising out of or relating to the
Loan Documents, (ii) agrees that all claims in respect of any such action or proceeding may be heard and determined in such courts, (iii) irrevocably waives (to the extent permitted by applicable law) any objection which it now or
hereafter may have to the laying of venue of any such action or proceeding brought in any of the foregoing courts, and any objection on the ground that any such action or proceeding in any such court has been brought in an inconvenient forum, and
(iv) agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner permitted by law. 

SECTION 9.11 Entire Agreement. The Loan Documents reflect the entire agreement between the Company, the Agent, and the Lenders
with respect to the matters set forth herein and therein and supersede any prior agreements, commitments, drafts, communication, discussions and understandings, oral or written, with respect thereto. 

SECTION 9.12 Severability. Whenever possible, each provision of the Loan Documents shall be interpreted in such manner as to be
effective and valid under all applicable laws and regulations. If, however, any provision of any of the Loan Documents shall be prohibited by or invalid under any such law or regulation in any jurisdiction, it shall, as to such jurisdiction, be
deemed modified to conform to the minimum requirements of such law or regulation, or, if for any reason it is not deemed so modified, it shall be ineffective and invalid only to the extent of such prohibition or invalidity without affecting the
remaining provisions of such Loan Document, or the validity or effectiveness of such provision in any other jurisdiction. 

SECTION 9.13 Counterparts. This Agreement may be executed in any number of counterparts and by different parties hereto in
separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute but one and the same agreement. 
 [signature pages follow] 

  
 26 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement, as of the date
first above written. 
  

			
	THE COMPANY
	  
 MARRONE BIO INNOVATIONS, INC.,

a Delaware corporation

		
	 By
	 	/s/ Pam Marrone
		 	 Title: Pam Marrone

  

			
	 Address: President and Chief Executive Officer

 
 2121 Second Street, Suite B-107

Davis, California 95618

Attn.: Chief Executive Officer
  

With a copy to:
  

Morrison & Foerster LLP

400 Capitol Mall
 Suite 2600
 Sacramento, California 95814

Attn.: Charles S. Farman, Esq.

 
			
	THE AGENT
	
	 /s/ Gordon Snyder
	Gordon Snyder

  

			
	 With a copy (which shall not constitute notice) to:

 
 Barrie Cowan, Attorney and
Counselor
 595 Laidley Street

San Francisco, CA 94131-3039

			
	LENDER:
	
	Dan and Danna Holmes Charitable
	Remainder Trust I
		
	By:	 	 /s/ Dan Holmes

	Name: Dan Holmes
	Title: Trustee
		
	By:	 	/s/ Danna Holmes
	Name: Danna Holmes
	Title: Trustee

 SIGNATURE PAGE TO LOAN AGREEMENT 

			
	LENDER:
	
	Dan and Danna Holmes Charitable
	Remainder Trust II
		
	By:	 	/s/ Dan Holmes
	Name: Dan Holmes
	Title: Trustee
		
	By:	 	/s/ Danna Holmes
	Name: Danna Holmes
	Title: Trustee

 SIGNATURE PAGE TO LOAN AGREEMENT 

	
	LENDER
	
	/s/ Lorna Pomeroy
	LORNA POMEROY

 SIGNATURE PAGE TO LOAN AGREEMENT 

	
	LENDER
	
	/s/ Cindy Evans
	CINDY EVANS

 SIGNATURE PAGE TO LOAN AGREEMENT 

			
	LENDER
	
	 CINDY EVANS CHARITABLE
 REMAINDER TRUST

		
	By:	 	/s/ Cindy Evans
		 	Cindy Evans, Trustee

 SIGNATURE PAGE TO LOAN AGREEMENT 

			
	LENDER
	
	 LINA TANS

	
	 /s/ Lina Tans

		 	Signature

 SIGNATURE PAGE TO LOAN AGREEMENT 

			
	LENDER
	
	 ANNE BERNDT 2012

GRANDCHILDREN’S TRUST UAD

10/01/12

		
	 By:
	 	 /s/ Anne Berndt

	 Trustee

 SIGNATURE PAGE TO LOAN AGREEMENT 

	
	LENDER
	
	/s/ Kevin Frank
	KEVIN FRANK

 SIGNATURE PAGE TO LOAN AGREEMENT 

			
	LENDER
	
	 JOHN AND WENDY EVANS

REVOCABLE TRUST

		
	By:	 	 /s/ John Evans

	Trustee
		
	By:	 	 /s/ Wendy Evans

	Trustee

 SIGNATURE PAGE TO LOAN AGREEMENT 

			
	LENDER
	
	 JOHN AND WENDY EVANS

CHARITABLE REMAINDER TRUST I

		
	By:	 	 /s/ John Evans 

	Trustee
		
	By:	 	 /s/ Wendy Evans 

	Trustee

 SIGNATURE PAGE TO LOAN AGREEMENT 

			
	LENDER
	
	 JOHN AND WENDY EVANS

CHARITABLE REMAINDER TRUST II

		
	By:	 	 /s/ John Evans 

	Trustee
		
	By:	 	 /s/ Wendy Evans

	Trustee

 SIGNATURE PAGE TO LOAN AGREEMENT 

			
	LENDER
	
	 JANE BLAIR VILAS REVOCABLE TRUST

		
	By:	 	/s/ Jane Blair Vilas
		 	Jane Blair Vilas, Trustee

 SIGNATURE PAGE TO LOAN AGREEMENT 

 SCHEDULE 1 

Commitments and Pro Rata Shares 
  

					
	 Lender
	  	 Commitment Amount
	 
	 Dan and Danna Holmes Charitable Remainder Trust I
	  	$	550,000	  
	 Dan and Danna Holmes Charitable Remainder Trust II
	  	$	450,000	  
	 Lorna Pomeroy
	  	$	1,000,000	  
	 Cindy Evans
	  	$	800,000	  
	 Cindy Evans Charitable Remainder Trust
	  	$	300,000	  
	 Lina Tans
	  	$	1,000,000	  
	 Anne Berndt 2012 Grandchildren’s Trust UAD 10/01/12 Anne Berndt TTEE
	  	$	750,000	  
	 Kevin Frank
	  	$	200,000	  
	 John and Wendy Evans Revocable Trust
	  	$	770,000	  
	 John and Wendy Evans Charitable Remainder Trust I
	  	$	400,000	  
	 John and Wendy Evans Charitable Remainder Trust II
	  	$	600,000	  
	 Jane Blair Vilas Revocable Trust
	  	$	680,000	  
	 Total
	  	$	7,500,000	  

 SCHEDULE 2 

Existing Indebtedness 
  

	1.	Indebtedness owed to Point Financial, Inc. (“Point”) pursuant to that certain Loan Agreement, dated as of April 13, 2012, by and between Marrone
Bio Innovations, Inc. (“MBI”) and Point, in an aggregate principal amount equal to $10,000,000, as such agreement may be amended, restated, supplemented or otherwise modified from time to time; provided, however, that the principal
amount of the indebtedness evidenced or secured by the Point Security Agreement is not increased except by an amount equal to a reasonable premium or other reasonable amount paid, and fees and expenses reasonably incurred, in connection with such
amendment, restatement, supplement or other modification. 

  

	2.	Indebtedness relating to that certain Convertible Note Purchase Agreement, dated as of March 15, 2012, by and among MBI and the Investors listed on the Schedule of
Investors attached thereto, as such agreement may be amended, restated, supplemented or otherwise modified from time to time; provided, however, that the principal amount of the indebtedness evidenced or secured by the Convertible Note Purchase
Agreement is not increased except by an amount equal to a reasonable premium or other reasonable amount paid, and fees and expenses reasonably incurred, in connection with such amendment, restatement, supplement or other modification.

  

	3.	Indebtedness owed to Five Star Bank in an aggregate principal amount up to $1,000,000, as the agreement relating to such Indebtedness may be amended, restated,
supplemented or otherwise modified from time to time; provided, however, that the principal amount of the indebtedness to Five Star Bank is not increased except by an amount equal to a reasonable premium or other reasonable amount paid, and fees and
expenses reasonably incurred, in connection with such amendment, restatement, supplement or other modification. 

 SCHEDULE 3 

Existing Liens 
  

													
	  	  	 Secured Party
	  	 Initial Filing Number
	 	  	 Initial Filing Date
	 	  	 Collateral Description

	 1
	  	Manufacturers’ Lease Plans, Inc.	  	 	2009 2917117	  	  	 	9/11/2009	  	  	Equipment
	 2
	  	Wells Fargo Foothill	  	 	2009 3286207	  	  	 	10/13/2009	  	  	Equipment
	 3
	  	Thermo Fisher Financial Services Inc.	  	 	2011 0842388	  	  	 	3/8/2011	  	  	Equipment
	 4
	  	Manufacturers’ Lease Plans, Inc.	  	 	2011 1307423	  	  	 	4/7/2011	  	  	Equipment
	 5
	  	Manufacturers’ Lease Plans, Inc.	  	 	2011 1486599	  	  	 	4/20/2011	  	  	Equipment
	 6
	  	Point Financial, Inc.	  	 	2012 1440108	  	  	 	7/13/2012	  	  	All assets
	 7
	  	Thermo Fisher Financial Services Inc.	  	 	2012 1830845	  	  	 	5/11/2012	  	  	Equipment
	 8
	  	Manufacturers’ Lease Plans, Inc.	  	 	2012 2469296	  	  	 	6/26/2012	  	  	Equipment
	 9
	  	Farnam Street Financial, Inc.	  	 	2012 2776104	  	  	 	7/19/2012	  	  	Equipment
	 10
	  	Five Star Bank	  	 	08-7158560393	  	  	 	5/20/2008	  	  	All assets
	 11
	  	Five Star Bank	  	 	2012 0023053	  	  	 	1/3/2012	  	  	All assets

 EXHIBIT A 

Form of Warrant 

 THIS WARRANT AND THE SHARES OF STOCK WHICH MAY BE PURCHASED UPON THE EXERCISE OF THIS WARRANT HAVE BEEN
ACQUIRED SOLELY FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE
OF SUCH REGISTRATION OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL THAT SUCH SALE, OFFER, PLEDGE OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT AND OF ANY APPLICABLE
STATE SECURITIES LAWS UNLESS SOLD PURSUANT TO RULE 144 OF THE ACT. 
 MARRONE BIO INNOVATIONS, INC. 

STOCK PURCHASE WARRANT 
 WARRANT TO PURCHASE SHARES OF STOCK 
 THIS CERTIFIES THAT, for value received, and
subject to the provisions and upon the terms and conditions hereinafter set forth below, as of the Exercise Date [                    ] (the
“Holder”) is entitled to subscribe for and purchase the number of shares of the fully paid and nonassessable shares of the Common Stock (the “Shares”) of Marrone Bio Innovations, Inc., a Delaware corporation (the
“Company”) as set forth below under the definition of Warrant Shares (as may be adjusted pursuant to Section 3 hereof). The capitalized terms used in this Warrant shall, to the extent not defined where first used, have the
meanings given to them in Section 20 of this Warrant. This Warrant is one of a series of warrants issued by the Company pursuant to the Loan Agreement dated as of [            ],
2012 (as amended, modified or supplemented, the “Loan Agreement”) between Company and the Lenders (as defined in the Loan Agreement). 
 1. Method of Exercise; Payment. 
 (a) Cash Exercise. The purchase
rights represented by this Warrant may be exercised by the Holder, in whole or in part, after the Exercise Date by the surrender of this Warrant (with the notice of exercise form attached hereto as Exhibit A duly executed) at the
principal office of the Company, and by the payment to the Company, by certified, cashier’s or other check acceptable to the Company, of an amount equal to the aggregate Exercise Price of the Shares being purchased. 

 (b) Net Issue Exercise. In lieu of exercising this Warrant, the Holder shall have the
right to convert this Warrant (or any portion thereof) by surrender of this Warrant at the principal office of the Company together with notice of such conversion on the form attached hereto as Exhibit A, in which event the Company shall
issue to the Holder a number of Shares computed using the following formula: 
  

					
	X =	 	Y (A-B)	 	
		 	A	 	

 Where X = the number of the Shares to be issued to the Holder. 

Y = the number of the Shares purchasable under this Warrant in respect of which the net issue exercise election is made pursuant to this
Section 1(b). 
 A = the fair market value of one share of the Shares. 

B = the Exercise Price on the date of conversion (as adjusted to the date of such conversion). 

(c) Fair Market Value. For purposes of this Section 1, the per share fair market value of the Shares shall mean: 

(i) If this Warrant is exercised as part of the consummation of the IPO as provided in Section 9(a), the per share fair market value of
the Shares shall be seventy percent (70%) of the price per share of Common Stock sold to the public in the IPO. 
 (ii) If if
this Warrant is exercised as part of the consummation of an Acquisition as provided in Section 9(b), the per share fair market value of the Shares shall be seventy percent (70%) of the value of one share of Common Stock sold or valued in the
Acquisition 
 (d) Stock Certificates. In the event of any exercise of the rights represented by this Warrant,
certificates for the Shares so purchased shall be delivered to the Holder within a reasonable time. Notwithstanding any delay in the delivery of the certificates for the Shares, the Company agrees that Shares purchased under this Warrant shall be
and are deemed to be issued to the Holder hereof as the record owner of such Shares as of the close of business on the date on which this Warrant shall be been surrendered, the completed exercise form and the payment of the purchase price has been
delivered (or, in the alternative the conversion notice specified in Section 1(b) has been delivered) to the Company. 
 2.
Stock Fully Paid; Reservation of Stock. All of the Shares issuable upon the exercise of the rights represented by this Warrant will, upon issuance and receipt of the Exercise Price therefor, be fully paid and nonassessable, and free from all
taxes, liens and charges with respect to the issue thereof. 

  
 -2-

 3. Adjustments. The number and kind of securities purchasable upon the exercise of
this Warrant and the Exercise Price therefor shall be subject to adjustment from time to time upon the occurrence of certain events, as follows: 
 (a) Reclassification. In case of any reclassification or change of the Common Stock (other than a change in par value, or as a result of a subdivision or combination), the Company shall execute a
new Warrant, providing that the holder of this Warrant shall have the right to exercise such new Warrant, and procure upon such exercise and payment of the same aggregate Exercise Price, in lieu of the shares of the Common Stock theretofore issuable
upon exercise of this Warrant, the kind and amount of shares of stock, other securities, money and property receivable upon such reclassification or change, by a holder of an equivalent number of shares of Common Stock. Such new Warrant shall
provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for in this Section 3. The provisions of this subsection (a) shall similarly apply to successive reclassifications or changes.

 (b) Stock Splits, Dividends and Combinations. In the event that the Company shall at any time subdivide the
outstanding shares of Common Stock or shall issue a stock dividend on its outstanding shares of Common Stock the number of shares issuable upon exercise of this Warrant immediately prior to such subdivision or to the issuance of such stock dividend
shall be proportionately increased, and the Exercise Price shall be proportionately decreased, and in the event that the Company shall at any time combine the outstanding shares of Common Stock the number of shares issuable upon exercise of this
Warrant immediately prior to such combination shall be proportionately decreased, and the Exercise Price shall be proportionately increased, effective at the close of business on the date of such subdivision, stock dividend or combination, as the
case may be. 
 4. Notice of Adjustments. Whenever the number of shares purchasable hereunder or the Exercise Price
thereof shall be adjusted pursuant to Section 3 hereof, the Company shall promptly provide notice to the Holder setting forth, in reasonable detail, the event requiring the adjustment, the amount of the adjustment, the method by which such
adjustment was calculated, and the number and class of shares which may be purchased and the Exercise Price therefor after giving effect to such adjustment. 
 5. Fractional Shares. This Warrant may not be exercised for fractional shares. In lieu of fractional shares the Company shall make a cash payment therefor based upon the Exercise Price then in
effect. 
 6. Representations of the Company. The Company represents that all corporate actions on the part of the
Company, its officers, directors and shareholders necessary for the sale and issuance of this Warrant and the performance of the Company’s obligations hereunder were taken, or will be taken, prior to and are, or will be, effective as of the
Exercise Date. 
 7. Representations and Warranties by the Holder. The Holder represents and warrants to the Company as
follows: 
 (a) This Warrant and the Shares issuable upon exercise thereof are being acquired for its own account, for
investment and not with a view to, or for resale in connection with, any 

  
 -3-

 
distribution or public offering thereof within the meaning of the Securities Act of 1933, as amended (the “Act”). Upon exercise of this Warrant, the Holder shall, if so requested
by the Company, confirm in writing, in a form satisfactory to the Company, that the securities issuable upon exercise of this Warrant are being acquired for investment and not with a view toward distribution or resale. 

(b) The Holder understands that the Warrant and the Shares have not been registered under the Act by reason of their issuance in a
transaction exempt from the registration and prospectus delivery requirements of the Act pursuant to Section 4(2) thereof, and that they must be held by the Holder indefinitely, and that the Holder must therefore bear the economic risk of such
investment indefinitely, unless a subsequent disposition thereof is registered under the Act or is exempted from such registration. The Holder further understands that the Shares have not been qualified under any state securities law by reason of
their issuance in a transaction exempt from the qualification requirements thereof, which exemption depends upon, among other things, the bona fide nature of the Holder’s investment intent expressed above. 

(c) The Holder has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks
of the purchase of this Warrant and the Shares purchasable pursuant to the terms of this Warrant and of protecting its interests in connection therewith. 
 (d) The Holder is able to bear the economic risk of the purchase of the Shares pursuant to the terms of this Warrant. 
 8. Restrictive Legend. 
 The Shares (unless registered under the Act) shall
be stamped or imprinted with a legend in substantially the following form: 
 THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE
BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF, AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUCH SHARES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF
SUCH REGISTRATION OR UNLESS THE COMPANY RECEIVES AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO IT STATING THAT SUCH SALE OR TRANSFER IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT. COPIES OF THE AGREEMENT COVERING
THE PURCHASE OF THESE SHARES AND RESTRICTING THEIR TRANSFER MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE COMPANY AT THE PRINCIPAL EXECUTIVE OFFICES OF THE COMPANY.

 9. IPO or Acquisition. 

  
 -4-

 (a) Upon receipt of a written notice of the Company’s intention to raise capital by
selling shares of Common Stock in an IPO, which notice shall be delivered to Holder at least thirty (30) but not more than ninety (90) days before the anticipated date of the consummation of the IPO, the Holder shall, within 10 days of receipt of
such notice, notify the Company whether or not the Holder will exercise this Warrant as part of the consummation of the IPO. If Holder has elected to exercise this Warrant as provided in this Section 9 in connection with an IPO and the IPO is not
consummated, then Holder’s exercise of this Warrant shall not be effective. 
 (b) Upon receipt of a written notice of the
Company’s intention to consummate an Acquisition, which notice shall be delivered to Holder at least thirty (30) but not more than ninety (90) days before the anticipated date of the consummation of the Acquisition, the Holder shall, within 10
days of receipt of such notice, notify the Company whether or not the Holder will exercise this Warrant as part of the consummation of the Acquisition. If Holder has elected to exercise this Warrant as provided in this Section 9 in connection with
an Acquisition and the Acquisition is not consummated, then Holder’s exercise of this Warrant shall not be effective. 

10. Rights of Shareholders. No holder of this Warrant shall be entitled, as a Warrant holder, to vote or receive dividends or be
deemed the holder of the Shares or any other securities of the Company which may at any time be issuable on the exercise hereof for any purpose, nor shall anything contained herein be construed to confer upon the holder of this Warrant, as such, any
of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or to give or withhold consent to any corporate action (whether upon any
recapitalization, issuance of stock, reclassification of stock, change of par value, consolidation, merger, conveyance, or otherwise) or, except as provided in Section 11 below, to receive notice of meetings, or to receive dividends or subscription
rights or otherwise until the Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have become deliverable, as provided herein. 
 11. Notices of Record Date. In the event: 
 (a) the Company shall declare any
dividend or distribution upon any of its capital stock; 
 (b) there shall be any capital reorganization, reclassification of
the capital stock of the Company or an Acquisition; or 
 (c) there shall be a voluntary or involuntary dissolution, liquidation
or winding up of the Company; 
 the Company shall give to the Holder of this Warrant written notice of any relevant record, payment, effective
and exchange dates and the amount and nature of any dividend, distribution or right. Such notice shall be given at least 10 days prior to any record date for distribution or voting and also at least 20 days prior to the effective date of the
transactions referred to in (b) and (c) above. Failure to so give notice or any defect in any certification or notice given under this Warrant shall not affect the validity or legality of any transaction giving rise thereto so long as such failure
or defect does not result in the termination of Holder’s rights under this Warrant. 

  
 -5-

 12. Expiration of Warrant. This Warrant shall expire and shall no longer be
exercisable upon the earlier to occur of: 
 (a) the date of the later of the Initial Maturity Date (as defined in the Loan
Agreement) or the later applicable maturity date (as such term is used in the Loan Agreement), if any; 
 (b) An Acquisition,
provided that the Company has complied with Section 9(b) in all material respects; and 
 (c) The IPO, provided that the Company
has complied with Section 9(a) in all material respects. 
 13. Notices. All notices and other communications required or
permitted hereunder shall be in writing, shall be effective when given, and shall in any event be deemed to be given upon receipt or, if earlier, (a) five (5) days after deposit with the U.S. Postal Service or other applicable postal service, if
delivered by first class mail, postage prepaid, (b) upon delivery, if delivered by hand, (c) one business day after the business day of deposit with Federal Express or similar overnight courier, freight prepaid or (d) one business day after the
business day of facsimile transmission, if delivered by facsimile transmission with copy by first class mail, postage prepaid, and shall be addressed (i) if to the Holder, at
[                                        
], and (ii) if to the Company, at the address of its principal corporate offices (attention: President), or at such other address as a party may designate by advance written notice to the other party pursuant to the provisions above. 

14. “Market Stand-Off” Agreement. Holder agrees not to sell or otherwise transfer or dispose of any Common Stock (or
other securities) of the Company held by Holder during a period of time determined by the Company and its underwriters not to exceed (180) days following the effective date of the Company’s initial registration statement. 

If requested by the Company, Holder agrees to enter into a separate agreement consistent with the foregoing with any underwriter of the
Company’s securities. Such agreement shall be in writing in a form reasonably satisfactory to the Company and such underwriter; provided, however, that such agreement (and the Holder’s obligation pursuant to the previous paragraph) shall
not be required unless all officers and directors (and related funds) of the Company and all other holders of at least 1% of the Company’s outstanding equity securities enter into similar agreements. The Company may impose stop-transfer
instructions with respect to the securities subject to the foregoing restriction until the end of said period. 
 15.
Governing Law. This Warrant and all actions arising out of or in connection with this Agreement shall be governed by and construed in accordance with the internal laws of the State of California, without regard to the conflicts of law
provisions thereof. 
 16. Exchange of Warrants. On surrender for exchange of this Warrant, properly endorsed, the
Company at its expense, but on payment by the Holder of any applicable transfer taxes, 

  
 -6-

 
shall issue and deliver to or on the order of the Holder a new Warrant or Warrants of like tenor, for the same aggregate number of Shares as called for by the Warrant surrendered. 

17. Replacement of Warrants. In the case of the loss, theft or destruction of a Warrant then held by Holder or his assigns, an
affidavit of an officer of such Holder stating the loss, theft or destruction, as the case may be, shall constitute evidence satisfactory to the Company and no indemnity or security shall be required for replacement other than the Holder’s
written agreement to indemnify the Company. 
 18. No Impairment. The Company shall not, by amendment of its Certificate
of Incorporation or bylaws, or through reorganization, consolidation, merger, dissolution, issue or sale of securities, sale of assets or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this
Warrant, but shall at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect the rights of the Holder of this Warrant against impairment.

 19. Severability. If any term, provision, covenant or restriction of this Warrant is held by a court of
competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Warrant shall remain in full force and effect and shall in no way be affected, impaired or invalidated.

 20. Certain Definitions. As used in this Warrant the following terms shall have the following respective meanings:

 “Acquisition” shall mean (a) the acquisition of the Company by another entity by means of any
transaction or series of related transactions (including, without limitation, any transfer of more than 50% of the voting power of the Company, reorganization, merger or consolidation, but excluding any merger effected exclusively for the purpose of
changing the domicile of the Company); or (b) a sale of all or substantially all of the assets of the Company; unless the Company’s stockholders of record as constituted immediately prior to such acquisition or sale will, immediately after
such acquisition or sale (by virtue of securities issued as consideration for the Company’s acquisition or sale or otherwise) hold at least fifty percent (50%) of the voting power of the surviving or acquiring entity. 

“Exercise Date” shall mean (a) if this Warrant is to be exercised as part of the consummation of the IPO as provided in
Section 9(a), the date immediately prior to the consummation of the IPO; and (b) if this Warrant is to be exercised as part of the consummation of an Acquisition as provided in Section 9(b), the date immediately prior to the consummation of the
Acquisition. 
 “Exercise Price” shall mean (a) if this Warrant is exercised as part of the consummation of the
IPO as provided in Section 9(a), the exercise price of a Share will be seventy percent (70%) of the price at which one share of Common Stock is sold to the public in the IPO; and (b) if this Warrant is exercised as part of the consummation of an
Acquisition as provided in Section 9(b), the exercise price of a Share will be seventy percent (70%) of the value of one share of Common Stock sold or valued in the Acquisition. 

  
 -7-

 “IPO” shall mean the Company’s firmly underwritten public offering
pursuant to a registration statement under the Securities Act of 1933, as amended, covering the offer and sale of Common Stock of the Company for the account of the Company in which the gross cash proceeds to the Company (before underwriting
discounts, commissions and fees) are at least $30,000,000. 
 “Warrant Shares” shall mean as to the Holder (a)
if this Warrant is exercised as part of the consummation of the IPO as provided in Section 9(a), the number of Shares as is equal to the quotient (rounded to the nearest whole number) obtained by dividing (i) the product obtained by multiplying the
original principal amount of such Holder’s Loan (as defined in the Loan Agreement) by 0.15, by (ii) seventy percent (70%) of the price at which one share of Common Stock is sold to the public in the IPO; and (b) if this Warrant is exercised as
part of the consummation of an Acquisition as provided in Section 9(b), the number of Shares as is equal to the quotient (rounded to the nearest whole number) obtained by dividing (i) the product obtained by multiplying the original principal amount
of such Holder’s Loan (as defined in the Loan Agreement) by 0.15, by (ii) seventy percent (70%) of the value of one share of Common Stock sold or valued in the Acquisition. 

Issued as of
[                    ], 2012. 
  

			
	MARRONE BIO INNOVATIONS, INC.
		
	By:	 	  

		
	Name:	 	  

		
	Title:	 	  

  
 -8-

 EXHIBIT A 

NOTICE OF EXERCISE 
  

	 	TO:	Marrone Bio Innovations, Inc. 

	 	    	2121 Second Street, Ste. B-107 

	 	    	Davis, CA 95618 

	 	    	Attention: President 

 1. The
undersigned hereby elects to purchase             shares of Marrone Bio Innovations, Inc. pursuant to the terms of the attached Warrant. 

2. Method of Exercise (Please initial the applicable blank): 
                      The undersigned elects to exercise the attached Warrant by means of a cash
payment, and tenders herewith payment in full for the purchase price of the Shares being purchased, together with all applicable transfer taxes, if any. 
                      The undersigned elects to exercise the attached Warrant by means of the net
exercise provisions of Section 1(b) of the Warrant. 
 3. Please issue a certificate or certificates representing said
Shares in the name of the undersigned or in such other name as is specified below: 
  

					
		 	  
	 	
		 	(Name)	 	
			
		 	  
	 	
			
		 	  
	 	
		 	(Address)	 	

 4. The undersigned hereby represents and warrants that the aforesaid Shares are being acquired for the
account of the undersigned for investment and not with a view to, or for resale, in connection with the distribution thereof, and that the undersigned has no present intention of distributing or reselling such shares and all representations and
warranties of the undersigned set forth in Section 7 of the attached Warrant are true and correct as of the date hereof. 
  

			
	  

	 (Signature)

		
	Title:	 	  

  

			
	  

	 (Date)

  
 -9-

 EXHIBIT B 

PROMISSORY NOTE 
  

			
	$                    	  	[City, State]
		  	                 , 2012

 FOR VALUE RECEIVED, MARRONE BIO INNOVATIONS, INC., a Delaware corporation (the
“Borrower”), hereby promises to pay to                      (the “Lender”), in lawful money of the United
States of America in immediately available funds, the principal sum of                      DOLLARS
($        ) or, if less, the unpaid principal amount of all Loans (as defined in the Agreement) made by the Lender pursuant to the Agreement, payable at such times and in such amounts as are
specified in the Agreement (as defined below). 
 The Borrower also promises to pay interest on the unpaid principal amount of
each Loan made by the Lender in like money from the date hereof until paid at the rates and at the times provided in Section 2.04 of the Agreement. 
 This Note is one of the Notes referred to in that certain Loan Agreement, dated as of                  , 2012
(as amended, restated, supplemented or otherwise modified from time to time, the “Agreement”; capitalized terms used herein and not otherwise defined herein shall have the meanings given to such terms in the Agreement), by and among
the Borrower, the lenders from time to time party thereto, and Gordon Snyder, an individual, as administrative agent and collateral agent for the Lenders (in such capacity, the “Agent”) and is entitled to the benefits thereof and of
the other Loan Documents. This Note is secured by the Security Agreements. As provided in the Agreement, this Note is subject to voluntary prepayment prior to the applicable maturity date, in whole or in part. 

In case an Event of Default shall occur and be continuing, the principal of and accrued but unpaid interest on this Note may be declared
to be due and payable in the manner and with the effect provided in the Agreement. 
 In addition to and not in limitation of
the foregoing and the provisions of the Agreement, the undersigned further agrees, subject to the cure periods set forth in the Agreement and any limitation imposed by applicable law, to pay all out-of-pocket expenses, including, without limitation,
attorneys’ fees and legal expenses, incurred by the holder of this Note in endeavoring to collect any amounts payable hereunder which are not paid when due, whether by acceleration or otherwise. 

THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WTH, THE LAW OF THE STATE OF CALIFORNIA. 

 
			
	 MARRONE BIO INNOVATIONS, INC.,
 a Delaware corporation

		
	By:	 	 
	Name:	 	 
	Title:	 	 

 SIGNATURE PAGE TO PROMISSORY NOTEEX-10.18

 Exhibit 10.18 
 SECURITY AGREEMENT 
 THIS SECURITY AGREEMENT (this “Agreement”),
dated as of October 2, 2012, is made among Marrone Bio Innovations, Inc., a Delaware corporation (“MBI”), Marrone Michigan Manufacturing, LLC, a Delaware limited liability company (“MMM” and together with MBI, collectively,
“Debtor”) and Gordon Snyder, an individual (“Snyder”), as collateral agent for the lenders party to the Loan Agreement referred to below (in such capacity, “Secured Party”). 

Debtor and Secured Party hereby agree as follows: 
 SECTION 1 Definitions; Interpretation. 
 (a) All capitalized terms used in
this Agreement and not otherwise defined herein shall have the meanings assigned to them in the Loan Agreement referred to below. 
 (b) As used in this Agreement, the following terms shall have the following meanings: 
 “Collateral” has the meaning set forth in Section 2(a). 

“Loan Agreement” means that certain Loan Agreement dated as of the date hereof by and among MBI, the lenders from time
to time party thereto, and Snyder, as administrative agent and collateral agent for such lenders, as such agreement may be amended, restated, supplemented or otherwise modified from time to time. 

“UCC” means the Uniform Commercial Code as the same may, from time to time, be in effect in the State of California.

 (c) Where applicable and except as otherwise defined herein, terms used in this Agreement shall have the meanings assigned to
them in the UCC. 
 (d) In this Agreement, (i) the meaning of defined terms shall be equally applicable to both the
singular and plural forms of the terms defined; and (ii) the captions and headings are for convenience of reference only and shall not affect the construction of this Agreement. 

SECTION 2 Security Interest. 
 (a) As security for the payment and performance of the Obligations, Debtor hereby grants to Secured Party as collateral agent, for itself and for the ratable benefit of the Lenders, a security interest in
all of Debtor’s right, title and interest in, to and under all of its (i) personal property, wherever located and whether now existing or owned or hereafter acquired or arising, including all accounts, chattel paper, commercial tort
claims, deposit accounts, documents, equipment (including all fixtures), general intangibles, instruments, inventory, investment property, letter-of-credit rights, money, and other goods, and (ii) real property and real property interests,
appurtenances, and fixtures, including rights of possession and use under leases and licenses, tenant improvements, and rights under options to lease or purchase and the like, and in the case of each of clauses (i) and (ii), all products,
proceeds and supporting obligations of any and all of the foregoing (collectively, the “Collateral”). The interest of any Lender in the Collateral shall be on a parity with the interests of all other Lenders, and the interest of each
Lender in the Collateral shall be ratable in the proportion that the aggregate indebtedness then outstanding and unpaid under the Note(s) held by such Lender bears to the aggregate indebtedness then outstanding and

  
 1 

 
unpaid under the Notes held by all Lenders (except to the extent the Lenders agree to any other ratable interest therein). 

(b) This Agreement shall create a continuing security interest in the Collateral which shall remain in effect until terminated in
accordance with Section 15 hereof. 
 (c) Notwithstanding the foregoing provisions of this Section 2, the grant of a
security interest as provided herein shall not extend to, and the term “Collateral” shall not include, any general intangibles of Debtor (whether owned or held as licensee or lessee, or otherwise), to the extent that (i) such general
intangibles are not assignable or capable of being encumbered as a matter of law or under the terms of the license, lease or other agreement applicable thereto (but solely to the extent that any such restriction shall be enforceable under applicable
law), without the consent of the licensor or lessor thereof or other applicable party thereto and (ii) such consent has not been obtained; provided, however, that the foregoing grant of security interest shall extend to, and the
term “Collateral” shall include, (A) any general intangible which is an account receivable or a proceed of, or otherwise related to the enforcement or collection of, any account receivable, or goods which are the subject of any
account receivable, (B) any and all proceeds of any general intangibles which are otherwise excluded to the extent that the assignment or encumbrance of such proceeds is not so restricted, and (C) upon obtaining the consent of any such
licensor, lessor or other applicable party’s consent with respect to any such otherwise excluded general intangibles, such general intangibles as well as any and all proceeds thereof that might have theretofore have been excluded from such
grant of a security interest and the term “Collateral”. 
 (d) Anything herein to the contrary notwithstanding, in no
event shall the Collateral include, and Debtor shall not be deemed to have granted a security interest in, any of Debtor’s right, title or interest in any of the outstanding voting capital stock or other ownership interests of a Controlled
Foreign Corporation (as defined below) in excess of 65% of the voting power of all classes of capital stock or other ownership interests of such Controlled Foreign Corporation entitled to vote; provided that (i) immediately upon the
amendment of the Internal Revenue Code to allow the pledge of a greater percentage of the voting power of capital stock or other ownership interests in a Controlled Foreign Corporation without adverse tax consequences, the Collateral shall include,
and Debtor shall be deemed to have granted a security interest in, such greater percentage of capital stock or other ownership interests of each Controlled Foreign Corporation; and (ii) if no adverse tax consequences to Debtor shall arise or
exist in connection with the pledge of any Controlled Foreign Corporation, the Collateral shall include, and Debtor shall be deemed to have granted a security interest in, such Controlled Foreign Corporation. As used herein, “Controlled Foreign
Corporation” shall mean a “controlled foreign corporation” as defined in the Internal Revenue Code. 
 (e)
Secured Party agrees that, notwithstanding the terms of any account control agreements, while no Event of Default exists, Secured Party (i) shall refrain from exerting control over any deposit or securities accounts subject to such account
control agreements, (ii) shall defer to Debtor’s control over the assets and proceeds in such accounts, including Debtor’s ability to withdraw from, or otherwise direct the disposition of funds from, deposit accounts for the payment
of Debtor’s obligations to third parties as they become due and payable, and including Debtor’s ability to withdraw from, designate investments in, or otherwise direct activities in its securities accounts, and (iii) shall not send a
“Notice of Exclusive Control” (or similar notice pursuant to which Secured Party purports to exert exclusive control over any deposit or securities account of Debtor) to the applicable bank, broker or other securities intermediary party to
an account control agreement. 

  
 2 

 SECTION 3 Financing Statements, Etc. Debtor hereby authorizes Secured Party to file
at any time and from time to time any financing statements describing the Collateral, and Debtor shall execute and deliver to Secured Party, and Debtor hereby authorizes Secured Party to file (with or without Debtor’s signature), at any time
and from time to time, all amendments to financing statements, assignments, continuation financing statements, termination statements, and other documents and instruments, in form reasonably satisfactory to Secured Party, as Secured Party may
reasonably request, to perfect and continue perfected, maintain the priority of or provide notice of the security interest of Secured Party in the Collateral and to accomplish the purposes of this Agreement. 

SECTION 4 Representations and Warranties. Debtor represents and warrants to Secured Party that: 

(a) Debtor is duly organized, validly existing and in good standing under the law of the jurisdiction of its organization and has all
requisite power and authority to execute, deliver and perform its obligations under this Agreement. 
 (b) The execution,
delivery and performance by Debtor of this Agreement have been duly authorized by all necessary action of Debtor, and this Agreement constitutes the legal, valid and binding obligation of Debtor, enforceable against Debtor in accordance with its
terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium, or similar debtor relief laws from time to time in effect which affect the enforcement of creditors’ rights in general and the
availability of equitable remedies. 
 (c) No authorization, consent, approval, license, exemption of, or filing or registration
with, any governmental authority or agency, or approval or consent of any other Person, is required for the due execution, delivery or performance by Debtor of this Agreement, except for any filings necessary to perfect any Liens on any Collateral.

 (d) Debtor’s exact legal name is as set forth in the first paragraph of this Agreement. 

(e) Debtor has rights in or the power to transfer the Collateral, and Debtor is the sole and complete owner of the Collateral, free from
any Lien other than Permitted Liens. 
 SECTION 5 Covenants. So long as any of the Obligations remain unsatisfied, Debtor
agrees that: 
 (a) Debtor shall do and perform all reasonable acts that may be necessary and appropriate to maintain, preserve,
and protect the Collateral. 
 (b) Debtor shall comply in all material respects with all laws, regulations and ordinances, and
all policies of insurance, relating in a material way to the possession, operation, maintenance and control of the Collateral. 

(c) Debtor shall give prompt written notice to Secured Party (and in any event not later than 60 days following any change described
below in this subsection) of: (i) any change in its name; (ii) any changes in its identity or structure in any manner which might make any financing statement filed hereunder incorrect or misleading; (iii) any change in its
registration as an organization (or any new such registration); or (iv) any change in its jurisdiction of organization. 

  
 3 

 (d) Debtor shall pay and discharge all material taxes, fees, assessments and governmental
charges or levies imposed upon it with respect to the Collateral prior to the date on which penalties attach thereto, except to the extent such taxes, fees, assessments or governmental charges or levies are being contested in good faith by
appropriate proceedings and are adequately reserved against in accordance with GAAP; provided that the failure to make any such payments shall not constitute a breach of this covenant unless the aggregate amount of such payments could
reasonably be expected to exceed $200,000. 
 (e) Debtor shall maintain and preserve its legal existence, its rights to transact
business and all other rights, franchises and privileges necessary or desirable in the normal course of its business and operations and the ownership of the Collateral, except in connection with any transactions expressly not expressly prohibited
hereunder. 
 (f) Upon the written request of Secured Party, Debtor shall promptly deliver to Secured Party, or an agent
designated by it, appropriately endorsed or accompanied by appropriate instruments of transfer or assignment, all documents and instruments, all certificated securities with respect to any investment property, all letters of credit and all accounts
and other rights to payment at any time evidenced by promissory notes, trade acceptances or other instruments. 
 (g) Upon
Secured Party’s written request, Debtor shall promptly notify Secured Party if Debtor holds or acquires (i) any commercial tort claims, (ii) any chattel paper, including any interest in any electronic chattel paper, or (iii) any
letter-of-credit rights. 
 SECTION 6 Events of Default. An “Event of Default” under the Loan Agreement shall
constitute an Event of Default hereunder. 
 SECTION 7 Remedies. 

(a) Upon the occurrence and during the continuance of any Event of Default, Secured Party may, by notice to Debtor, declare any of the
Obligations to be immediately due and payable and shall have, in addition to all other rights and remedies granted to it in this Agreement, all rights and remedies of a secured party under the UCC and other applicable laws. 

(b) The cash proceeds actually received from the sale or other disposition or collection of Collateral, and any other amounts received in
respect of the Collateral the application of which is not otherwise provided for herein, shall be applied to the payment of the Obligations as set forth in the Loan Agreement. Any surplus thereof which exists after payment and performance in full of
the Obligations shall be promptly paid over to Debtor or otherwise disposed of in accordance with the UCC or other applicable law. 
 SECTION 8 Notices. All notices or other communications hereunder shall be provided in accordance with Section 9.02 of the Loan Agreement. 

SECTION 9 No Waiver; Cumulative Remedies. No failure on the part of Secured Party or any Lender to exercise, and no delay in
exercising, any right, remedy, power or privilege hereunder shall operate as a waiver thereof, nor shall 

  
 4 

 
any single or partial exercise of any such right, remedy, power or privilege preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The
rights and remedies under this Agreement are cumulative and not exclusive of any rights, remedies, powers and privileges that may otherwise be available to Secured Party and the Lenders. 

SECTION 10 Binding Effect. This Agreement shall be binding upon, inure to the benefit of and be enforceable by Debtor, Secured
Party, each Lender and their respective successors and assigns and shall bind any Person who becomes bound as a debtor to this Agreement. 
 SECTION 11 Governing Law. This Agreement shall be governed by, and construed in accordance with, the law of the State of California, except as required by mandatory provisions of law and to the
extent the validity or perfection of the security interests hereunder, or the remedies hereunder, in respect of any Collateral are governed by the law of a jurisdiction other than California. 

SECTION 12 Entire Agreement; Amendment. This Agreement, the Loan Agreement, any note executed by Debtor to evidence the
obligations of Debtor to Secured Party, and any other Loan Document, taken together, contain the entire agreement of the parties with respect to the subject matter hereof and shall not be amended except by the written agreement of the parties.

 SECTION 13 Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to
be effective and valid under all applicable laws and regulations. If, however, any provision of this Agreement shall be prohibited by or invalid under any such law or regulation in any jurisdiction, it shall, as to such jurisdiction, be deemed
modified to conform to the minimum requirements of such law or regulation, or, if for any reason it is not deemed so modified, it shall be ineffective and invalid only to the extent of such prohibition or invalidity without affecting the remaining
provisions of this Agreement, or the validity or effectiveness of such provision in any other jurisdiction. 
 SECTION 14
Counterparts. This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall
constitute but one and the same agreement. 
 SECTION 15 Termination. Upon payment and performance in full of all
Obligations, the security interest created under this Agreement shall terminate and Secured Party shall promptly execute and deliver to Debtor such documents and instruments reasonably requested by Debtor as shall be necessary or appropriate to
evidence termination of all security interests given by Debtor to Secured Party hereunder. 
 SECTION 16 Joint and Several
Liability. If Debtor consists of more than one Person, the liability of each Person comprising Debtor shall be joint and several, and each reference herein to “Debtor” shall mean and be a reference to each such Person comprising
Debtor. The Debtors agree that 

  
 5 

 
any and all of their obligations hereunder shall be the joint and several responsibility of each of them notwithstanding any absence herein of a reference such as “jointly and
severally” with respect to any such obligation. The compromise of any claim with, or the release of, any Debtor shall not constitute a compromise with, or a release of, any other Debtor. 

SECTION 17 Conflicts. In the event of any conflict or inconsistency between this Agreement and the Loan Agreement, the terms of
this Agreement shall control. 
 SECTION 18 Confidentiality. Secured Party covenants and agrees, on a continuing basis,
to use reasonable efforts to maintain the confidentiality of and not to disclose to any person other than its officers, directors, attorneys and accountants and subsidiaries and affiliates, and such other persons to whom Secured Party shall at any
time be required to make such disclosure in accordance with applicable law, any and all proprietary, trade secret or confidential information provided to or received by Secured Party from or on account of Debtor or any subsidiary or affiliate of
Debtor, including business plans and forecasts, non-public financial information, confidential or secret processes, formulae, devices or contractual information, customer lists, employee relation matters, and any other information the disclosure of
which could reasonably be expected to have a material adverse impact on the business, finances or operations of Debtor or its subsidiaries and affiliates; provided, however, the foregoing provisions shall not be effective regarding the
disposition of Collateral after an Event of Default. 
 [remainder of page intentionally left blank] 

  
 6 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement, as of the date
first above written. 
  

			
	 MARRONE BIO INNOVATIONS, INC.,
 a Delaware corporation

		
	By:	 	 /s/ Pam Marrone

	Name:	 	Pam Marrone
	Title:	 	President and Chief Executive Officer

  

			
	 MARRONE MICHIGAN
 MANUFACTURING, LLC,
 a Delaware limited liability company

		
	By:	 	/s/ Pam Marrone
	Name:	 	Pam Marrone
	Title:	 	Chief Executive Officer

 

	
	
	/s/ Gordon Snyder
	GORDON SNYDER

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00218-of-00352.parquet"}]]